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1 The heart is a self-renewing organ. 
 
1.1 Cardiac primitive cells. Till few years ago the scientific community considered the heart as 
a terminally differentiated post mitotic organ in which the cell number is defined soon after birth. 
According to this view the post-natal heart would depend uniquely on the hypertrophic growth of 
preexisting cells in order to reach the adult dimension. This would imply that cardiac cells have 
to maintain their viability throughout the life of the organism. Moreover, if this were the case, cell 
death had to be a very rare event to avoid the progressive loss of the cardiac mass over time. 
It is somehow difficult to imagine a human cardiomyocyte contracting on average 70 times per 
minute 24 hours a day for 80 years or more without considering the hypothesis of a cell turnover 
dedicated to the preservation of tissue homeostasis. Conversely, it is reasonable to envision 
that in the heart, like in several other organs and tissues, a limited number of primitive cells with 
self-renewing properties is constantly maintained in an undifferentiated-low proliferative state 
and that a fraction of these cells undergoes differentiation following physiological or pathological 
stimuli. Newly formed differentiated cells may preserve cardiac homeostasis and replace 
damaged tissue after injury. 
This scenario is anything but uncommon in other organs in which cells with these properties 
have been described. All organs of the organism contain two categories of cells: non-dividing 
cells and dividing cells. However non-dividing cells could be temporarily arrested in G0 in a 
dormant condition and be capable of reentering the cell cycle following growth activation and 
becoming terminally differentiated loosing permanently their ability to divide (Zhu and Skoultchi, 
2001). This phenomenon has been described in the small intestine at the tip of the villi 
(Mariadason et al., 2005), in the auditory cells of the ear (Chen et al., 2003) and in the upper 
layer of the epidermis (Hotchin et al., 1995). In the liver, hepatocytes are arrested in G0 and it is 
well known that, after injury, the hepatic tissue is able to regenerate thanks to the proliferation of 
several cell types including hepatocytes, biliary epithelial cells and fenestrated endothelial cells 
(Taub, 2004). The liver contains also undifferentiated cells, the oval cells, which could contribute 
to the regeneration process of the hepatic tissue after expansion and maturation into fully 
mature cells (Vessey and de la Hall, 2001). Although the possible mechanism underlying liver 
regeneration is still debated, the existence of primitive cells playing a major role in tissue 
homeostasis and regeneration has been proven and accepted in the bone marrow 
(hematopoietic stem cells) (Uchida et al., 1998), in the skin (skin stem cells) (Blanpain et al., 
2004), in the central nervous system (neural stem cells) (Eriksson et al., 1998; Lie et al., 2005; 
Rakic, 2004; Sanai et al., 2004) and in the skeletal muscle (satellite cells) (Dhawan and Rando, 
2005) (Fig. 1). 
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In our laboratory it has been recently demonstrated that the heart contains its own stem cell 
compartment since putative primitive cells have been characterized in the heart of small and 
large mammals including humans (Beltrami et al., 2003; Linke et al., 2005; Martin et al., 2004; 
Matsuura et al., 2004; Oh et al., 2003). Resident cardiac stem cells (CSCs) have been isolated 
from the myocardium and described as self-renewing, multipotent and clonogenic (Bearzi et al., 
2007; Beltrami et al., 2003; Linke et al., 2005).  
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Figure 1: Primitive cells in different tissue. (A) Hematopoietic stem cells (HSCs), their commitment to the myeloid and lymphoid 
progenitors and their differentiation into blood mature cells. (B) Skin stem cells localized in the bulge and in the sebaceous gland of the 
dermis and in the basal layer of the epidermis. (C) Neural stem cells (NSCs) and their commitment to neuronal and glial progenitors and 
their differentiation into mature cells. (D) Skeletal muscle stem cells (satellite cells) and their involvement in the repair of damaged 
myofibers and in the generation of new myofibers. 
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Such properties are essential for the maintenance of the stem cell pool and, at the same time, 
for the replacement of the cardiac cell lineages (cardiomyocyte, smooth muscle cells, 
endothelial cells and fibroblasts). 
The immunophenotypic features of CSCs are still under further investigation due to the technical 
difficulties encountered in their isolation and in the distinction between the true stem cells and 
their early committed progeny. In this regard, FACS analysis has been utilized for the 
characterization and enrichment of the different categories of cardiac primitive cells. However, 
this approach implies cell membrane permeabilization for the detection of cytoplasmic antigens 
precluding the possibility to utilize viable cells for further experiments. 
So far, the main marker that has been utilized in our laboratory for the identification and the 
isolation of putative CSCs is the stem cell antigen c-kit that is the receptor for the stem cell 
factor (SCF).  Its presence at the level of the cell membrane may be coupled with the presence 
of other two molecules that are expressed, although not uniquely, in undifferentiated cells: Sca-1 
(stem cell antigen-1) considered the predominant stem cell marker in the mouse bone marrow 
(Leri et al., 2005; Nadin et al., 2003; Shizuru et al., 2005), and MDR1 (multi drug resistance-1) 
that belongs to the ABC family of transporters that mediate the efflux of the Hoechst dye out of 
the cell in the side population of bone marrow (Bunting, 2002; Bunting et al., 2000) and skeletal 
muscle (Goodell et al., 2005; Leri et al., 2005; Majka et al., 2003). CSCs are classically 
characterized by the presence of the stem cell-related markers c-kit, Sca-1 and MDR-1 in 
variable combinations. Quantitative data in the mouse, rat, dog and human heart demonstrated 
that there is one CSC per 30,000-40,000 myocardial cells and that ~65% of them express the 
three stem cell antigens c-kit, Sca-1 and MDR1 together, ~20% express two stem cell antigens 
and ~15% express only one of them (Leri et al., 2005; Linke et al., 2005; Urbanek et al., 2005). 
CSCs do not express transcription factors and membrane or cytoplasmic proteins of bone 
marrow cells, neural cells, skeletal cells and cardiac cells and, therefore, they are considered 
lineage negative. True CSCs divide rarely and remain in an undifferentiated dormant status till 
their activation. Additionally, they are consistently small in size (~7 µm of diameter) and they 
have a high nucleus-to-cytoplasm ratio (Fig. 2). As mentioned before, CSCs are typically self-
renewing (able to give rise to a cardiac stem cell progeny), clonogenic (able to form clones in 
culture) and multipotent (able to differentiate into cardiomyocytes, smooth muscle and 
endothelial cells). 
CSCs have to undergo molecular and morphological modifications in order to become fully 
differentiated. The hallmark of premature commitment of a CSC is the nuclear expression of 
cardiac transcription factors (GATA4, GATA6, Mef2C, Nkx2.5, and Ets1 among others) that 
define their lineage destiny. At this stage of maturation, the cells usually retain the stem cell 
marker c-kit (Sca-1 and/or MDR1) and are classified as cardiac progenitor cells. 
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When progenitor cells start to express cardiac transcription factors together with membrane or 
cytoplasmic proteins (i.e. contractile proteins: α-sarcomeric actin, smooth muscle actin) they 
enter a more mature state and they are classified as cardiac precursor cells. These cells can 
be negative for the stem cell marker c-kit (Sca-1 and/or MDR1) and appear larger in size being 
the cytoplasmic component more present (Fig. 3). Considering the expression of cardiac 
transcription factors and cytoplasmic proteins, it has been documented by our laboratory that 
clonogenic CSCs (positive for c-kit and/or Sca-1 and/or MDR1 in different combinations) 
preferentially differentiate into myocytes (~30-32%), to a less extent into smooth muscle (~22-
29%) and endothelial (~6-12%) cells and fibroblasts (~12-18%) in culture. Importantly, c-kit 
positive CSCs showed a greater clonogenic capacity than that of Sca-1-like positive, MDR1 
positive and c-kit-Sca-1-like-MDR1 positive CSCs. 
Cardiac progenitor and precursor cells (CPCs) can actively divide giving rise to a pool of 
transient amplifying committed cells identified by the expression of cardiac transcription 
factors together with myofibrillar proteins and cell cycle markers such as Ki67 and MCM5 
(Urbanek et al., 2003). This fraction of cells represents a valuable resource for the replacement 
of old and damaged cells.  
Following a proliferation phase and the accomplishment of the differentiation program, young 
myocytes undergo progressive hypertrophy and, in the end, they permanently exit the cell cycle 
becoming positive for p16INK4a (inhibitor of cell cycle and marker of cell senescence).  
Interestingly, the lifespan of myocytes seems to correlate with their volume; in this regard, 
young, amplifying myocytes are less than 180 µm2 in cross-sectional area, adult non dividing 
cells are 200-250 µm2, old non dividing cells are 300-500 µm2 and senescent non dividing cell 
are 600-900 µm2 (Rota et al., 2007; Urbanek et al., 2003). 
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c-Kit   GATA4 c-Kit   Mef2c MDR-1   GATA4 MDR-1   Mef2c 
c-Kit    α-sarc Sca-1   Mef2c   α-sarc MDR-1   Mef2c    α-sarc 
Figure 3: Commitment of primitive cells with cardiac hypertrophy. (A and B; the same field) A cardiac progenitor (A, arrowhead) 
shows c-kit on the surface membrane (green) and GATA-4 (A, red) in the nucleus, and the myocyte progenitor (B, arrow) exhibits 
in its nucleus GATA-4 (A, red) and MEF2 (B, white). (C and D; the same field) A cardiac progenitor (C, arrowhead) shows MDR1 
on the surface membrane (purple) and GATA-4 (C, red) in the nucleus, and a myocyte progenitor (D, arrow) exhibits in its nucleus 
GATA-4 (C, red) and MEF2 (D, white). (E, F, and G) Myocyte precursors (arrows) show on the surface membrane c-kit (E, green), 
MDR1 (F, purple), or Sca-1-like (G, yellow). A thin cytoplasmic layer is positive for cardiac myosin (E-G, red) and nuclei express 
MEF2 (E-G, white). (Bars = 10 µm). From: (Urbanek et al., 2003). 
c-Kit MDR-1 Sca-1 
Figure 2: Putative cardiac stem cells. Shown are the detection of c-kit (A, green), MDR1 (B, purple), and Sca-1-reactive protein (C, 
yellow) in primitive cells (arrows) of hypertrophied hearts. Nuclei are stained by propidium iodide (PI; blue) and myocytes by 
cardiac myosin (red). (Bars = 10 µm). From: (Urbanek et al., 2003). 
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1.2 The cardiac niche. In several organs the stem cells are stored in organized 
microenvironments, called niches, which protect them from adverse stimuli. By definition, a 
niche is characterized by two components: the stem cells, which are located in the inner portion 
of the niche, and the surrounding supporting cells (Fig. 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A considerable amount of information regarding the structure and the signaling regulatory 
mechanisms of the niche has been collected in D. melanogaster (Spradling et al., 2001). In 
specific organs of simple organisms, such as the Drosophila gonad, the architectural 
organization of the tissue gives reliable reference points that make the identification of the 
niches relatively easy (Lin, 2002). Conversely, in mammals, the localization of a stem cell niche 
presents several obstacles related to the more complex architecture of the tissue. 
However, this task is simplified in organs with an epithelial lining that offers a useful reference 
point for the identification of the region in which the supporting cells reside. This is particularly 
apparent in the skin (Tumbar et al., 2004) in the bulge of the hair follicles (Cotsarelis, 2006) and 
in the intestine (Kim and Shibata, 2002).  
The stem cells stored within a niche have the capability to perpetuate themselves following (a) 
symmetric division through which two self-renewing daughter stem cells are formed and/or (b) 
asymmetric division resulting in the generation of one daughter stem cell and one committed 
amplifying cell which give rise to a progeny of newly differentiated cells. Additionally, symmetric 
division can produce two daughter-committed cells (c) and this event ends up with a progressive 
depletion of the stem cell pool in the niche over time (Watt and Hogan, 2000) (Fig. 5).  
Stem cell niche 
Stem cell 
Supporting cell 
Figure 4: Schematic representation of a stem cell niche.  
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Similarities in the spatial arrangement of putative stem cells and committed cells can be found in 
the mouse bone marrow (Yoshimoto et al., 2003) and in the rat brain (Doetsch, 2003; Palmer, 
2002), providing important elements of analogy between these organs and the heart. It has 
been recently demonstrated that CSCs and CPCs are stored in niches in the adult heart (Leri et 
al., 2005; Urbanek et al., 2006), (Appendix). Lineage negative cells expressing a stem cell 
marker c-kit, Sca-1 or MDR1, separately or in combination, have been detected clustered 
together with progenitor and precursors cells. In such clusters it is possible to recognize also 
small myocytes and other cells in early phases of differentiation (Anversa et al., 2003).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A cardiac niche is defined by CSCs and their committed progeny (CPCs) surrounded by 
terminally differentiated cardiomyocytes and fibroblasts that function as supporting cells. The 
cells forming a niche are structurally and functionally interconnected through adherent junctions 
(N, E-cadherins and β-catenin) and gap junctions (connexins 40, 43 and 45) that guarantee 
mechanical and functional coupling, respectively. These connections are necessary to 
physically keep the stem cells within the niche and to preserve stem cell characteristics (Fuchs 
et al., 2004; Urbanek et al., 2006). Additionally, different classes of integrins expressed on the 
stem cell surface mediate the interaction of stem cells with the intercellular matrix and regulate 
stem cell migration (Urbanek et al., 2006) (see Appendix). Although small clusters of CSCs are 
scattered throughout the entire myocardium, true cardiac niches are preferentially located in 
regions with low exposure to mechanical stress such as the atria and the apex. Cardiac niches 
Stem cell 
2 stem cells 
2 committed cells 
Stem cell 
1 stem cell    1 committed cell 
Asymmetric division Symmetric division 
or 
Figure 5: Scheme of asymmetric and symmetric cell division in which different proportions of undifferentiated and committed cells 
are formed. One committed cell and one stem cell are formed after asymmetric cell division (b), two stem cells (a) or two 
committed cells (c) are formed after symmetric cell division. 
 
(a) 
(b) 
(c) 
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are more rarely found in regions of the heart exposed to a high hemodynamic load such as the 
base and the mid portion of the left ventricle (Fig. 6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Within a niche, a stem cell maintains a quiescent state by its anchorage to a neighboring 
supporting cell; when the stem cell starts to proliferate and differentiate this connection is lost. 
Committed cells are able to change location within the niche and, eventually, to leave the niche 
environment in response to specific stimuli migrating into areas of the tissue where new 
parenchymal cells and new vessels have to be formed. In this regard, mechanical deformation 
and high wall stress represent physical stimuli able to trigger cell migration, proliferation, 
differentiation and death (Estes et al., 2004; Leri et al., 2005). The combination of these events 
dictates the homeostasis of the cardiac niche. 
Figure 6: Schematic representation of CSC niches. Cardiac niches are prevalently located in the atria and apex and consist of 
differentiated myocytes that surround clusters of CSCs and highly dividing amplifying cells. The amplifying cells are committed cells 
and express transcription factors of the cardiac (GATA-4), myocyte (MEF2C), smooth muscle cell (GATA-6), and endothelial cell 
(Ets1) lineages. The interaction among CSCs, early committed cells (ECCs), and supporting cells occurs via junctional proteins 
(cadherins and connexins). From: (Leri et al., 2005). 
 10 
The balance between proliferation and apoptotic death depends not only on the cell itself but 
also on the signals coming from the surrounding environment that reflect the needs of the organ. 
This phenomenon has been studied and well characterized during embryonic and fetal 
development. If the same equilibrium is operative in the adult heart and if the same mechanisms 
may be impaired in pathological condition, it is still under investigation. 
Importantly, apoptosis is a phenomenon occurring not only in differentiated, progenitors and 
precursor cells, but also in stem cells, which were considered until recently an example of 
immortal cells. The role of apoptosis in the definition of the stem cell number in a niche and 
throughout the parenchyma has been recently demonstrated in the bone marrow (Domen et al., 
2000), the intestine (Renehan et al., 2001), the brain (Lindsten et al., 2003) and the heart 
(Anversa et al., 2006; Chimenti et al., 2003; Urbanek et al., 2005). 
 
1.3 CSCs and the biology of myocardial regeneration. The old paradigm that the heart is a 
post mitotic organ is slowly shifting to the new exciting notion that views the heart as a self 
renewing organ in which tissue homeostasis is maintained by a delicate balance of three 
different, although related processes: cell death, cell proliferation and cell differentiation. 
Experimental observations on the human, murine and dog heart have demonstrated two 
important phenomena. First, myocyte can divide as documented by the activation of the cell 
cycle machinery coupled with BrdU incorporation, histone-H3 phosphorylation and Ki67, MCM5, 
Cdc6 and cyclin B1 expression in myocyte nuclei (Leri et al., 2005) indicating that the heart is 
not a post mitotic organ. Second, myocardial regeneration spontaneously occurs in humans 
following ischemic (Beltrami et al., 2001; Leri et al., 2005; Urbanek et al., 2005) and non-
ischemic injury (Leri et al., 2005; Urbanek et al., 2003), confirming that the heart is an organ with 
self-renewing properties (Fig. 7). The documentation of mitotic figures in myocytes forced the 
researchers to answer the fundamental question concerning the origin of this subpopulation of 
replicating myocytes. Essentially there are two possibilities: a dedifferentiation process involving 
mature myocytes or a generation of newly formed dividing myocytes by the activation and 
differentiation of primitive cells. The former possibility implies that a fully mature cell could go 
backwards the differentiation program, disassembling the myofibrillar apparatus and reentering 
the cell cycle. This represents a quite complex and biologically challenging event. However, the 
documentation of the existence of resident CSCs, originally in the rat heart and subsequently in 
dogs, pigs, rats, mice and humans, gave the opportunity to see the process of myocyte 
proliferation under a new light (Anversa et al., 2006). 
We now know that the mammalian heart contains self-renewing, multipotent and clonogenic 
primitive cells able to differentiate into the main cardiac cell lineages (cardiomyocytes, smooth 
muscle cells, endothelial cells and fibroblasts). These properties are fundamental for the 
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maintenance of tissue homeostasis and, importantly, represent a prerequisite for myocardial 
regeneration. 
This dynamic view of the heart has been reinforced in the last few years by several laboratories 
that have documented the presence of a stem cell compartment in the heart (Anversa et al., 
2006). The activation of such cells and the consequent continuous turnover of myocytes result 
in a heterogeneous cell population consisting of young, adult, old and senescent myocytes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Myocyte proliferation and activation of resident primitive cells both take place adjacent to 
(border zone) and far from the infarcted region. However, in mammals, (at variance with 
amphibians) this population of cells fails to colonize the dead tissue and differentiating in mature 
myocytes to fully restore the myocardium. The limited ability of mammalian tissues to repair the 
damage still remains without a reasonable explanation. In this regard, the physiological and 
Figure 7: Myocardial regeneration in the 
human heart. A: an area of spontaneous 
formation of myocytes (-sarcomeric actin, 
red) is present in proximity of dead, infarcted 
myocardium and a region of inflammatory 
reaction. B and C: metaphase chromosomes 
(PI, blue and phospho-histone H3, yellow) 
are apparent in two small dividing myocytes 
(cardiac myosin heavy chain, red) in the heart 
of patients affected by chronic aortic stenosis. 
Modified from: (Urbanek et al., 2003). 
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molecular events that underlie myocardial regeneration are still poorly understood. However, 
some factors have been identified as possible candidates. For example, the insulin-like growth 
factor-1 (IGF-1) and the hepatocyte growth factor (HGF) have been proposed as important 
molecules able to trigger cell proliferation and survival and cell migration, respectively (Linke et 
al., 2005). In this regard, CSCs and early committed cells express the HGF receptor (c-Met) and 
the insulin-like growth factor-1 (IGF-1) receptor and can synthesize and secrete the 
corresponding ligands HGF and IGF-1. Activated CSCs injected in the border zone of the infarct 
and stimulated with a cocktail of IGF-1 and HGF reconstituted dead myocardium and recovered 
myocardial functions in infarcted mice (Urbanek et al., 2005). 
Importantly, mechanical deformation and high wall stress have been proven to mimic the effects 
triggered by chemokine and growth factors in terms of cell migration, proliferation, differentiation 
and death (Estes et al., 2004; Sadoshima and Izumo, 1997). 
An important aspect addressing the issue of myocardial regeneration is represented by the 
extracellular matrix. Myocardial infarction has two effects: cell death and disassembly of the 
tissue scaffold. As in every organ, the parenchymal cells and the extracellular network constitute 
two interdependent components of the heart. The experimental observations of the regenerated 
heart have shown that the structural organization of the newly formed myocardium is 
characterized by myocytes oriented longitudinally to the tangential stress. The absence of the 
more complex tissue organization (cardiomyocyte bundles) typical of the ventricular wall may 
depend, in part, on the disruption of the extracellular scaffold. The usage of biomaterials for the 
synthesis of self-assembling scaffolds has become recently a novel and common strategy 
(Davis et al., 2005; Eschenhagen and Zimmermann, 2005). These scaffolds can drive an 
orderly growth of myocytes and coronary vessels and can be loaded with peptides able to 
stimulate the differentiation and the mobilization of resident progenitor cells (Koh and Atala, 
2004; Narmoneva et al., 2004). Additionally, the combination of tissue engineering with self-
assembling biomaterials and cell therapy with CSCs/CPCs may offer more powerful tools to 
overcome the injured heart.  
However, a better understanding of the cardiac niche and a deep knowledge of the molecular 
mechanisms of tissue homeostasis would allow the stimulation of resident CSCs to become 
functionally competent, the induction of their migration and translocation from the niches to 
reach and repair the damaged tissue. This approach may provide new hints to face tissue injury 
offering new tools to induce myocardial regeneration and counteract tissue deterioration in the 
pathologic and aged heart. 
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2. Notch pathway overview. 
 
In recent years a substantial body of evidence supported the notion that molecular pathways 
classically involved in tissue specification during embryonic development (Shh, Wnt and Notch) 
may be also operative in adult self-renewing organs (Wilson and Radtke, 2006). 
The evolutionary conserved Notch pathway is 
one of the most important mechanisms that 
controls binary cell fate decisions during 
embryonic development and tissue homeostasis 
in adult life (Bray, 2006). The Notch gene was 
named for the phenotype of a mutation in D. 
melanogaster causing characteristic indentations 
(notches) in the rear portion of the fruit fly’s wing 
(Morgan, 1917) (Fig. 8). The identification of new 
alleles allowed the studies on the recessive 
neurogenic phenotype (Metz and Bridges, 1917; 
Poulson, 1939) and, over the years, the analysis 
of these phenotypes eventually led to the 
discovery of different functions of Notch. 
Most importantly, in the last few years, three different Notch activities during development have 
been uncovered: lateral inhibition, boundary formation and cell fate assignation (Bray, 1998). 
The first insights into the function and mode of action of Notch signaling came from studies in D. 
melanogaster and C. elegans (Fehon et al., 1990; Greenwald, 1985; Wharton et al., 1985; 
Yochem et al., 1988) which allowed the discovery of a core set of molecules involved in Notch 
signaling and led to the understanding of how they organize into a signaling pathway. 
To date, four Notch isoforms have been described in mammals: Notch1 to Notch4 (Artavanis-
Tsakonas et al., 1999). The Notch receptors are large single-pass type I transmembrane 
proteins and exist at the cell surface as a proteolytically cleaved heterodimer comprising a large 
ectodomain (Notch extracellular domain, NECD) and a membrane-tethered intracellular domain 
(Notch intracellular domain, NICD). Notch receptors interact with single-pass type I 
transmembrane ligands expressed on neighboring cells and this restricts the Notch pathway to 
regulating short-range intercellular interactions through lateral inhibition or inductive interaction 
(Bray, 2006). 
In mammals, there are five genes encoding the Notch ligands: three Delta-like (DLL1, DLL3 and 
DLL4) (Bettenhausen et al., 1995; Dunwoodie et al., 1997; Shutter et al., 2000) and two Jagged 
(JAG1 and JAG2) (Lindsell et al., 1995; Shawber et al., 1996a) (Fig. 9). 
Notches 
Figure 8: Notch wings phenotype. (left to right) average, 
extreme condition, nearly normal. 
From: (T.H. Morgan, “The physical basis of heredity”, 
1919). 
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In Drosophila, there is only one Notch-encoding gene, one Delta and one Jagged homologues 
(Lissemore and Starmer, 1999; Maine et al., 1995). In C. elegans, there are two genes encoding 
for Notch (lin-12 and glp-1) and several Delta/Serrate/Lag-2 (DSL) homologues (Greenwald, 
1994; Lissemore and Starmer, 1999; Maine et al., 1995). The study of the genetics of simpler 
organisms such as C. elegans and D. melanogaster has provided enormous insights into the 
mechanics of Notch signaling and has paved the way for a better understanding of how Notch 
acts in higher eukaryotes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Structure of mammalian Notch receptors and their ligands. Mammals possess 4 Notch receptors (Notch1‑4) and five 
ligands (Jagged1 and 2, and Delta-like 1, 3 and 4). Notch receptors are expressed on the cell surface as heterodimeric proteins. 
They are composed of an extracellular domain (NECD) and an intracellular domain (NICD). NECD contains up to 36 EGF-like repeats 
that mediate the interaction between Notch and its ligands, a cysteine-rich region known as Lin-12 repeats (LNR) and 
heterodimerization domains that bind non-covalently to the membrane-tethered intracellular Notch. NICD contains a RAM domain 
(RBPjk Associate Molecule), repeated structural motifs named Ankyrin repeats that mediate the interaction between Notch and 
CBF1/Su(H), two nuclear localization sequences (NLS), a transactivation domain (TAD) and a PEST domain that is involved in the 
degradation of Notch. Notch ligands Delta (Dll1, 3 and 4) and Jagged (Jagged1 and 2) are also expressed on the cell surface. The 
extracellular domains contain a Delta/Serrate/Lag2 (DSL) domain unique to Notch ligands and also contain multiple EGF repeats. 
Jagged1/2 also contains a cysteine-rich domain and a von Willebrand factor type C domain. The intracellular domains of Jagged1 
and Dll1 have been shown to contain PDZ domains, which may interact with downstream signaling components to activate 
transcription. From:(Niessen and Karsan, 2007). 
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Notch receptor activation. The Notch receptor mediates molecular signaling between two 
neighboring cells. Upon binding with its ligands, the Notch receptor undergoes conformational 
changes that allow a proteolytic cleavage at the level of the Notch ectodomain. This event is 
catalyzed by metalloproteinases of the ADAM family and determines the release of the NECD 
from the cell membrane. Following a second proteolytic cleavage mediated by the γ-secretase 
complex NICD is released from the inner surface of the cell membrane. The presence of nuclear 
localization sequences (NLSs) targets the NICD to the nucleus (Fig. 10). Once in the nucleus, 
the NICD forms a complex with the sequence-specific DNA-binding protein of the CSL family 
RBP-jk (recombination signal binding protein for immunoglobulin kappa J region). In the 
absence of NICD, the RBP-jk protein binds to specific DNA sequences in the regulatory 
elements of various target genes and represses their transcription by recruiting histone 
deacetylases and other components to form a co-repressor complex. The nuclear translocation 
of NICD displaces the histone deacetylase-co-repressor complex from the RBP-jk protein. The 
NICD-RBP-jk complex recruits other proteins, such as the mastermind-like 1 (MAML1) protein 
and histone acetyltransferases, leading to the transcriptional activation of Notch target genes 
(Tanigaki and Honjo, 2007). 
Among the most commonly induced Notch target genes are the basic helix-loop-helix (bHLH) 
transcriptional repressors of the hairy and enhancer of split/hairy and enhancer of split related 
with YRPW motif (Hes/Hey) family (Iso et al., 2003b; Kageyama et al., 2007). 
Functions of the Notch pathway. The Notch signaling results in the up-regulation or in the down-
regulation of transcription in several cell systems under physiologic and pathologic conditions. 
For this reason the Notch pathway has been described as a mechanism with a typical 
pleiotropic effect (Fig. 11). 
The Notch pathway is a major determinant of binary cell fate decision that is achieved by two 
processes: lateral inhibition and asymmetric cell division. 
Lateral inhibition is a fundamental mechanism dedicated to the definition of cell fate and cell 
spatial patterning during development and is probably the best characterized function of the 
Notch pathway (Heitzler and Simpson, 1993; Le Borgne and Schweisguth, 2003). Although 
lateral inhibition is a phenomenon mainly observed in insect neurogenesis (Niessen and 
Karsan, 2007) (Gibert and Simpson, 2003; Martin-Bermudo et al., 1995; Parks et al., 1997), 
there are data documenting that this process takes place in mice during hair cell development in 
the inner ear (Kiernan et al., 2005). Asymmetric cell division relies on cell polarization and is 
characterized by an asymmetric distribution of cell fate determinants before cell division that 
induces the different cell fate identity of the daughter cells. 
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Figure 10: The Notch signaling pathway. Notch 
receptors undergo processing in the trans-Golgi 
network by Furin and are expressed on the cell 
surface as a non-covalently linked heterodimer 
stabilized by a calcium ion. Receptor-ligand 
interaction results in 3 additional cleavage events 
that result in the release of the ectodomain (S2) 
and the intracellular region of the Notch receptor 
(S3, S4). The ectodomain of the Notch receptor 
and the ligand are thought to be endocytosed by 
the signaling cell. NICD then translocates to the 
nucleus, where it binds and converts CSL from a 
transcriptional repressor to a transcriptional 
activator of the Hes and Hey family of genes. 
Notch signaling is negatively regulated by 
hyperphosphorylation of nuclear NICD by the 
nuclear kinase CycC:CDK8, which is recruited to 
NICD by the Notch pathway coactivator MAML. 
From: (Niessen and Karsan, 2007). 
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The best example of asymmetric cell division is in D. melanogaster neurogenesis. The 
asymmetric distribution of regulators of Notch signaling activity (Bazooka, Numb and Neuralized 
among others) determines the identity of the daughter cells as signal-sending or signal-receiving 
cells. Once Notch signaling is elicited, the cells differentiate according to binary cell fate decision 
mediated by Notch (Frise et al., 1996; Hutterer and Knoblich, 2005; Le Borgne and 
Schweisguth, 2003). Asymmetric cell division is a mechanism occurring also in vertebrate 
species as suggested by recent data (Knoblich, 2001). 
Another important example of binary cell fate choices is the role of Notch in the maintenance of 
stem cell populations. Notch mediates the decision whether a cell should differentiate or remain 
in an undifferentiated state both in embryonic and in post-natal stem cell systems (Chiba, 2006).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Pleiotropic effect of the Notch pathway. The four major roles of the Notch cascade that are relevant within self-renewing 
tissues or during tumorigenesis are schematically illustrated. A. Gate-keeper function: Notch maintains stem and/or transient 
amplifying cells (TA) in an undifferentiated state. In the intestine for example, Notch prevents crypt progenitor cells (TA) from 
differentiating. B. Binary cell fate decisions: In the lymphoid system Notch specifies the T cell lineage at the expense of the B cell 
lineage from an (at least) bi-potent early thymocyte progenitor. C. Induction of differentiation: In the skin, Notch induces terminal 
differentiation events of TA cells, and during thymocyte differentiation Notch1 promotes differentiation of pro‑T cells into pre‑T 
cells. D. Tumorigenesis: Overexpression of Notch within hematopoietic bone marrow cells or in T cell progenitors results in T cell 
leukemias, and as such, Notch functions as an oncogene. However in the skin, Notch functions as a tumor suppressor since loss 
of Notch signaling results in the development of basal cell carcinoma-like tumors. From: (Radtke F. web site]. 
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The effects of Notch on the maintenance of stemness or initiation of the differentiation process 
are dose-, context- and time-dependent and, therefore, Notch modulates multiple phases of cell 
growth and turnover (Bray, 2006; Tanigaki and Honjo, 2007). Although Notch signaling ensures 
a proper balance between stem cells and their progeny, Notch may interfere or favor cell 
commitment. This lineage switch is apparent in the skin where Notch inhibits the formation of 
epidermal keratinocytes and promotes the generation of hair follicles (Estrach et al., 2006). 
Similarly the effects of Notch on bone marrow cells vary according to the state of maturation of 
the stimulated cells (Tanigaki and Honjo, 2007). The synthesis of the Notch ligand Jagged1 by 
osteoblasts increases the number of hematopoietic stem cells in the bone marrow niches (Calvi 
et al., 2003). In contrast, Notch activation in hematopoietic progenitors induces the generation of 
T lymphocytes (Radtke et al., 1999; Wilson et al., 2001). In the brain, Notch signaling expands 
the pool of immature precursors and enhances glial formation (Androutsellis-Theotokis et al., 
2006). 
For completeness it is important to underline that increasing evidence has been collected in 
support of the notion that Notch can effect multiple cellular processes independently from its 
CBF/Su(H) activity. For example, in vertebrates, Notch has been shown to inhibit skeletal muscle 
cell differentiation in a CSL-independent manner (Shawber et al., 1996b). 
The Notch pathway plays also a role in boundaries formation during somitogenesis in 
vertebrates or in invertebrates during the establishment of the D/V boundary in the wing imaginal 
disc (de Celis and Bray, 1997; Major and Irvine, 2005; Micchelli et al., 1997). 
Lastly, given the importance of Notch signaling in development it is not surprising that several 
human diseases are linked to defects of genes involved in Notch signaling (see Table 1). 
Mutations of the Jagged1 gene are responsible for the Alagille syndrome, an autosomal 
dominant mutation that causes liver, kidney, eye, heart and skeleton developmental 
abnormalities (Artavanis-Tsakonas, 1997; Li et al., 1997; Oda et al., 1997). Mutations of the 
human Notch1 and Notch3 are responsible for the cerebral autosomal dominant arteriopathy 
with subcortical infarcts and leukoencephalopathy syndrome (CADASIL) (Gridley, 2003; Harper 
et al., 2003). Deregulation of Notch signalling activity is at the basis of T-cell acute lymphoblastic 
leukaemia (Sjolund et al., 2005; Weng et al., 2004). Finally, a family of diseases, spondylocostal 
dysostosis, is caused by mutations of Dll3 and is characterized by vertebral defects (Gridley, 
2003). 
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Notch pathway defects and human disease
Disase Cause
Alagille syndrome mutations on the Jagged1 gene.
CADASIL mutations on Notch1 and Notch3.
syndrome
T cell acute mutation involving either the Notch heterodimerization domai or the PEST
lymphoblasic leukemia domain. Translocation of a truncated form of Notch resulting in signaling
Hyperactivation.
Spondylocostal mutations in Dll3. Epigenetic results suggest Lunatic Fringe mutations
dysostosis (SD) could also cause SD.
Table 1: Notch and diseases. 
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3. The Notch pathway in the cardiovascular system. 
 
3.1 Notch and cardiac development. The heart is the first functional organ that is formed 
during vertebrate development (Fig. 12). In mice at embryonic day 7 (E7.0) cardiac markers 
start to be expressed in the primitive streak (one of the first sign of gastrulation). At this stage 
cardiac precursors expressing CITED2 (considered the earliest transcriptional activator 
expressed during heart development) undergo epithelial-to-mesenchymal transformation (EMT) 
and migrate bilaterally from the primitive streak forming the primary heart field (left and right) 
(Schlange et al., 2000). This event corresponds to the expression of the transcription factors 
Mesp1 and Mesp2 (Kitajima et al., 2000). The endoderm underlying the primary heart field plays 
an important role in the definition of the cardiac phenotype due to the secretion of several 
factors including the bone morphogenetic protein (BMP) family, sonic hedgehog (Shh) and 
fibroblast growth factor 8 (FGF-8). Additionally the ectoderm and the endoderm secrete Wnt 
inhibitors required for the induction of the cardiogenic fate. Even at this early stage of 
development, the compartmentalization of heart chambers occurs (atrial precursors in the 
posterior region and ventricular precursors in the anterior region of the heart field) and the main 
markers of the primary heart field are apparent (Nkx2.5, BMP2, GATA4, GATA5, GATA6 and 
Tbx20) (Redkar et al., 2001). 
During development the right and left heart fields undergo anterior-medial migration and 
subsequently fuse at the anterior giving rise to the cardiac crescent. The cardiac crescent is 
quickly divided into a ventral myogenic domain (future myocardium of the heart tube) and a 
dorsolateral non-myogenic domain (future mesocardial and pericardial roof cells) (Raffin et al., 
2000). 
As in several other organs, the Notch pathway plays an important role during heart 
development. Evidence has been accumulated that the Notch signaling controls cardiac cell fate 
downstream of heart field specification. In this regard, it has been documented in X. laevis that 
the activation of the Notch pathway by the ligand Serrate1 suppresses the myogenic potential of 
the cells residing in the dorsolateral domain; however, the expression of the primary heart field 
markers Nkx2.5 and GATA4 are unaffected (Rones et al., 2000). Additionally, in CSL-deficient 
mouse embryos the primitive heart tube and heart field specification appear normal (Oka et al., 
1995; Souilhol et al., 2006). 
During subsequent folding of the embryo the cardiac crescent fuses into a tube-like structure 
that starts to beat at E8.0 in the mouse and after about 3 weeks of gestation in humans. 
A secondary heart field located in the splanchnic mesoderm and expressing common cardiac 
markers such as Nkx2.5 and GATA4 together with peculiar markers such as Nkx3.1 and FGF-
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10, has been identified in the chick and mouse embryos, but its contribution to the adult heart 
remains unclear (Kelly and Buckingham, 2002; Schneider et al., 2000). 
The primitive heart tube undergoes conformational changes (heart tube looping) that align and 
fuse the heart chambers. Data support a function of the Notch pathway in heart tube looping. At 
this stage Notch pathway inhibition (null mouse embryos for CSL or Notch and embryos 
deficient for Dll1) produces randomized heart looping and axial rotation (Krebs et al., 2003; 
Przemeck et al., 2003; Raya et al., 2003). However, these effects are not reproduced in Notch1-
deficient and Notch2-deficient embryos (Hamada et al., 1999; Krebs et al., 2003). 
At E9.5 the mouse cells of the atrio-venticular (AV) canal and the outflow tract (OFT) are 
activated by signals originated in the myocardium and by inter-endocardial signaling pathways 
to undergo endothelial-to-mesenchymal transition (EMT). This process is necessary for the 
formation of mesenchymal cells from the endocardial cell during cardiac cushion development. 
As development progresses mesenchymal cells proliferate determining the fusion of the cardiac 
cushions within the heart tube lumen forming the initial septa. The cardiac cushions undergo 
further remodeling producing protruding leaflets composed by endocardial cell and extracellular 
matrix that concur to the formation of the cardiac valves. The Notch pathway is involved in the 
onset of EMT during heart development. Loss and gain-of-function studies have revealed that 
Notch1, Notch4 and Dll4 are expressed at the beginning of the EMT in the AV canal and in the 
OFT. Both Notch1-deficient and CSL-deficient mouse embryos show a significant reduction in 
the EMT at the level of the AV canal (Timmerman et al., 2004). Additionally, zebrafish injected 
with constitutively active Notch1 resulted in ipercellularized AV tract and enlarged valves as a 
result of increased EMT (Timmerman et al., 2004). Another indication that Notch signaling in 
clearly involved in EMT is provided by in vitro experiments showing that the activation of the 
Notch pathway in endothelial cells resulted in EMT (Noseda et al., 2004). 
The role played by the Notch pathway in EMT seems to be restricted only to the initial phases of 
this process and does not appear to be required for the maintenance of the mesenchymal 
phenotype as indicated by the high expression of Hey2 (target of Notch) at the onset of EMT 
and its absence in the mesenchymal cells. 
Notch is important for the proper trabeculation of the ventricle since Notch-deficient embryos 
show a decrease in myocardial proliferation early in development. Ventricular chamber 
morphogenesis, first manifested by trabeculae formation, is crucial for cardiac function and 
embryonic viability. In this regard, Notch1 expression is found to be highest at the presumptive 
trabecular endocardium and, importantly, RBP-jk and Notch1 mutants show impaired 
trabeculation (Grego-Bessa et al., 2007). Additionally, Notch signaling plays an important role in 
the differentiation of cardiac conduction cell lineage in the ventricles. Notch1 expression 
coincides with the expression of a conduction marker, HNK-1, at early stages. The expression 
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of constitutively active Notch1 (NICD) in early heart tubes in chick produced a significant 
increase in the expression of conduction cell markers HNK-1 and SNAP-25 (Chau et al., 2006). 
However, this study reported a significant decrease in the expression of cardiac muscle markers 
in cell positive for NICD. 
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Figure 12: Cardiac Development. Cardiac precursors are identifiable in the anterior third of the primitive streak (blue and yellow), 
but not in the node (dark grey). As embryonic development progresses the heart precursors undergo EMT and migrate bilaterally 
from the primitive streak forming the left and the right heart fields (E7.5). The primary and secondary (green) heart fields undergo 
anterior-medial migration and fusion forming the cardiac crescent (E8.0). The primitive heart tube is formed by the fusion of the 
cardia crescent at embryonic midline at E8.5. The primary heart field gives rise to the left ventricle (blue), right ventricle (purple) 
and atria (yellow) while the secondary heart field gives rise to the cells of the outflow tract (green). The heart tube undergoes 
elongation at the atrial and ventricular ends and looping forming a C-shaped structure is initiated shortly after the formation of the 
heart tube (E8.5). At E9.5 EMT is initiated in the AV canal (red) and OFT (green) and the cardiac cushions become cellularized by 
EMT. EMT-derived cells from the AV contribute to the membranous atrial septum and mitral and tricuspid valvs, while OFT EMT-
derived cells combined with the neural crest-derived cells contribute to the aortic and pulmonary valves. Panels at E9.5 and E11.5 
represent images of mouse embryonic hearts at the respective stages. From (Niessen and Karsan, 2007). 
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3.2 Notch and vascular development. During development the endothelial cells originates 
from the embryonic mesoderm and in particular from mesodermal progenitors constituting the 
angioblast. The angioblast initially differentiates into a primary vascular plexus that following 
extensive remodeling gives rise to arteries, veins and capillaries. 
Although the expression of the components of the Notch pathway is dynamic during 
development rendering complicated their detection, three Notch receptors (Notch1, 3 and 4), 
three Notch ligands (Dll4, Jagged1 and 2) and three Notch effectors (HERP1, 2 and 3) seem to 
be involved in the vascular system (Iso et al., 2003a). 
The Notch pathway is important for arterial specification and this is in line with the fact that even 
though the Notch pathway components are initially expressed throughout the developing 
cardiovascular system, they are typically restricted to cells that will acquire an arterial fate later 
in development. In this regard, the primary vascular plexus (E9.5) is characterized by the 
expression of Notch1, Notch4 and Dll4, but later (E13.5) the receptors Notch1, Notch2 and 
Notch4 and the Notch ligands Dll4, Jagged1 and Jagged2 result mainly expressed in the arterial 
endothelium (Villa et al., 2001). In mice, Notch1/Notch4-double deficient and Dll4-deficient 
embryos display defects in arterial specification (Gale et al., 2004; Krebs et al., 2004; Krebs et 
al., 2000; Xue et al., 1999). 
The capillary endothelium is also characterized by the expression of Notch1, Notch4 and Dll4. 
Smooth muscle cells express high levels of Notch3 and Jagged1, but low level of Notch1 (Villa 
et al., 2001). Interestingly, it has been reported that, after injury, arteries express several Notch 
receptors and Notch ligands (Lindner et al., 2001). 
Concerning the molecular patterning in arterial vein specification, recent studies have produced 
data supporting a sequential activation of Shh, vascular-endothelial growth factor (VEGF) and 
Notch in a signaling cascade in which Shh is upstream of VEGF and VGEF is upstream of 
Notch (Niessen and Karsan, 2007). The connection between these molecules has been 
demonstrated in zebrafish in which Shh deficiency resulted in the decrease of VEGF expression 
and loss of arterial specification (Lawson et al., 2002). 
Evidence exists that Notch target genes play a role in the arterial-venous specification. In this 
regard, mouse embryos double deficient for Hey1 and Hey2 display defects in arterial 
specification (Fischer et al., 2004). Additionally, experiments conducted in zebrafish highlighted 
the function of gridlock (Hey homolog in D. rerio) in promoting arterial specification and inhibiting 
vein specification (Zhong et al., 2001; Zhong et al., 2000). However, opposite results have been 
obtained (Lawson et al., 2001).  
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Preliminary remarks: 
 
  
Although the role of the Notch pathway has been described in the developing heart, the 
contribution of this molecular signaling to tissue homeostasis in the adult heart remains largely 
unknown. 
 
The goal of the present study was to uncover possible implications of the Notch pathway 
during myocyte formation in the adult mouse heart. In particular my interest has been 
focused on a possible connection between the activation of the Notch1 receptor and the 
up-regulation of the cardiomyocyte transcription factor Nkx2.5 that is one of the earliest 
marker of cardiomyocyte lineage specification. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This study has been developed at the Cardiovascular Research Institute, 
New York Medical College, Valhalla, NY in the laboratory led by Prof. Piero Anversa. 
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RESULTS. 
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1. Abstract 
 
The Notch pathway mediates cell fate decision in multiple organs by regulating the expression 
of transcription factors that control cell differentiation. In the current work we tested the 
hypothesis that Nkx2.5 is a target gene of Notch1 and thereby regulates myocyte commitment in 
the adult mouse heart. Cardiac progenitor cells (CPCs) in the Niches express the Notch1 
receptor and the supporting cells exhibit the Notch ligand Jagged1. In CPCs stimulated with 
Jagged1, the nuclear translocation of Notch1 intracellular domain (NICD) was coupled with the 
up-regulation of Nkx2.5 and the formation of cycling myocytes in vitro. NICD and RBP-jk form a 
protein complex in CPCs that, in turn, binds to the promoter of the Nkx2.5 gene initiating 
transcription. In contrast, transcription factors of vascular cell lineages are down regulated 
following Jagged1 stimulation and Notch1 activation. Consistent with these in vitro observations, 
inhibition of Notch1 signaling in infarcted mice impaired cardiomyogenesis. Conversely, the 
commitment of resident CPCs to myocytes that retained a high proliferative state was preserved 
in control animals. These results indicate that Notch1 activation favors the early commitment of 
CPCs to the myocyte lineage, but the expression of Nkx2.5 does not abrogate their ability to 
divide. Cycling Nkx2.5 positive myocytes correspond to a transient amplifying cells which 
condition the replicative capacity of the heart in physiologic and pathologic states. 
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2. Notch1 activation favors cardiomyocyte differentiation through the expression of the 
cardiac transcription factor Nkx2.5. 
 
2.1. Cardiac niches contain Notch1-positive CPCs. Notch signaling controls the size and the 
composition of stem cell niches in several organs (Androutsellis-Theotokis et al., 2006; Calvi et 
al., 2003; Song et al., 2007). c-kit-positive CPCs are organized in niches that are located 
preferentially in the atria and in the apex of the adult heart (Urbanek et al., 2006). To establish 
whether the Notch pathway was involved in the maintenance of mouse CPCs homeostasis, the 
first step was to demonstrate the presence of the components of the Notch pathway (Notch 
receptors and Notch ligands) in CPCs within a niche. Most cardiac niches in the mouse heart 
contain Notch1 positive CPCs that are nested in the myocardial interstitial space and are 
connected to the surrounding myocytes by the junctional proteins connexins 43 and N-cadherin 
(Fig. 13).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Cardiac progenitors, c-kit and Notch1 receptor.  (A-D) Cardiac niche in normal mouse myocardium. Majority of c-kit-
positive cells (green) express Notch1 receptor (B, magenta). Connexin 43 (C, white dots, arrowheads) is present between c-kit-
positive cells and between c-kit-positive cells and myocytes (a-sarcomeric actin, a-SA, red); (D) merge and distribution of fibronectin 
(yellow) and collagen (light blue).  
 
A 
C 
B 
D 
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The presence of such connections demonstrates that Notch1 positive CPCs are functionally and 
mechanically connected to the surrounding myocardium. Importantly, the Notch ligand Jagged1 
is expressed in proximity of c-kit positive CPCs and is distributed at the interface between CPCs 
and between CPCs and myocytes (Fig. 14). The Notch ligand Delta-like-4 does not show a 
similar distribution being present predominantly in coronary vessels (Fig. 15). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. (A-C) c-kit-positive cells (green) located in 
the atrial myocardium; (B and C) distribution of Jagged1 
(white, arrows) between c-kit-positive cells and myocyte.  
A 
B 
C 
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2.2. Notch1 regulates CPCs commitment. Given the existence of Notch1-positive CPCs in the 
mouse heart and because of the role that Notch plays in stem cell fate, we assessed first the 
degree of expression of this receptor in freshly isolated mouse CPCs. By immunocytochemistry, 
an average of 60% of CPCs were Notch1 positive. Notch1 was restricted to CPCs lacking the 
expression of the transcription factor GATA4, employed as a marker of cell commitment 
(Urbanek et al., 2006). This suggested that the presence of the intact form of the Notch1 
receptor identified lineage negative CPCs. Only 20% of Notch1 negative CPCs expressed 
GATA4 (Fig). Importantly, c-kit and the other Notch receptor isoforms Notch2, Notch3 and 
Notch4 were found in ~10% of cells, pointing to Notch1 as the major component of the Notch 
pathway in CPCs (Fig. 16). 
Because the number of progenitor cells, ~250, in the adult mouse heart is small (Urbanek et al., 
2006), CPCs were expanded in vitro to characterize the effect of Notch1 on cell differentiation. 
Therefore, freshly isolated CPCs at late passages (P8-11) were employed for these studies. The 
properties of CPCs at baseline were assessed by immunocytochemistry: 60 ±11% and 35±2% 
of cultured CPCs was c-kit positive and expressed Notch1, respectively. 
 
 
Figure 15: Small vessel in normal mouse myocardium. Smooth muscle cells (α-smooth muscle actin, a-SMA, red) express the 
Notch ligand Delta-like-4 (white). Bar=10µm. 
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Figure 16. (A) Cytospin preparation of c-kit-positive CPCs: c-kit-positive cells (green) co-express Notch1 receptor. (B) c-kit-
positive (green) Notch1-positive (red) cells (arrows) are negative for GATA4 (white dots). (C) Notch1, 2 and 3 isoforms expression 
in c-kit positive cells. 
A 
B 
C 
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Importantly, 63±11% of c-kit positive cells expressed Notch1 and 96±2% of Notch1 positive cells 
were c-kit positive. Cultures of CPCs were then exposed to the immobilized Jagged1 ligand in 
the presence or absence of γ-secretase inhibition (Kornilova, AY JBC 2003); the γ-secretase 
cleaves the Notch1 receptor and, thereby, releases NICD activating the transcription of Notch1 
dependent genes (Fortini, 2002). Conversely γ-secretase blockers interfere with Notch1 
function.  
Since Hes1 is a well-established target gene of Notch, its expression was employed to 
document the state of activation and inhibition of the Notch1 pathway in CPCs. Jagged1 
resulted in a time dependent increase in the quantity of Hes1 transcript while γ-secretase 
inhibition markedly attenuated, although did not abrogate, Hes1 transcription (Fig. 17). The short 
half-life of the γ-secretase inhibitor may oppose complete repression of the Notch pathway. 
Based on these results, the consequences of Jagged1 stimulation together with γ-secretase 
inhibition on the localization of NICD in CPCs were measured at 2, 5 and 8 days after plating. 
Similarly, the expression of Nkx2.5 and GATA4 was determined to identify committed CPCs. For 
this purpose, CPCs were stained with an antibody that recognized exclusively the active cleaved 
form of Notch1, NICD. The loss of the extracellular domain of Notch1 was accompanied by the 
translocation of NICD to the nucleus. In contrast, NICD was absent in cells that displayed high 
Notch1 expression on the plasma membrane. Intermediate stages of co-localization were also 
present (Fig. 18).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17: Notch pathway activation with Jagged1 in the absence (Jag1) and presence of gamma-secretase inhibitor (Jag1+g). 
Hes1 mRNA levels measured by real time RT-PCR at 2 (2d), 5 (5d) and 8 (8d) days in culture. Fold change vs. Ctrl at 2 days. 
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Figure 18. Notch1 stimulation and nuclear localization of its active form (Notch intracellular domain, NICD).  Majority of stimulated 
CPCs express NICD in their nuclei (yellow) and are negative for c-kit. CPC in which Notch pathway remains not active (arrow) 
continue to express Notch1 (red) and c-kit (green) on the cell surface.  
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Following Jagged1 stimulation, the percentage of CPCs positive for Notch extracellular domain 
decreased dramatically from 2 to 5 days and remained low at 8 days (Fig. 19). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To identify the function of Notch1 in the acquisition of the myocyte lineage by CPCs, the 
expression of NICD, Nkx2.5 and GATA4 was established. Nkx2.5 was consistently co-
expressed with NICD and Jagged1 markedly enhanced this association and myocyte formation 
(Fig. 20). In the presence of Jagged1, the fraction of CPCs positive for NICD and Nkx2.5 
increased sharply at 5 days after stimulation and remained elevated at 8 days (Fig. 21). The up-
regulation of NICD promoted by Jagged1was not characterized by a comparable response of 
Nkx2.5 in CPCs at 2 days. However the induction of these two proteins was essentially identical 
at 5 and 8 days, suggesting that the transcriptional regulation of Nkx2.5 in CPCs may depend 
partly on Notch1 activation. Importantly blockade of Notch1 signaling abrogated Jagged1 
function. These histochemical results were confirmed by real time RT-PCR (Fig. 22). 
Conversely, Notch1 activation had a negative impact on GATA4; the number of GATA4 positive 
CPCs increased with γ-secretase inhibition pointing to a repressive role of the Notch1 pathway 
in the transcription of GATA4 (Fig. 23). 
 
 
 
 
 
 
Figure 19. Jagged1 stimulation and Notch1 receptor activation. Notch1 activation in stimulated cells (Jag1) at 2, 5 and 8 days in 
culture results in a significant loss of the membrane-bound Notch1 receptor compared to non-stimulated cells (Ctrl).  
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Figure 20. (A-D) Notch1 stimulation and inhibition affect cardiomyocyte commitment of CPCs. (A and B) Jagged1-stimulated CPCs 
express NICD (green) together with Nkx2.5 (magenta) in their nuclei. Area included in the square is shown at higher magnification 
in the inset. (C and D) Majority of Jagged1-stimulated CPCs in presence of γ-secretase inhibitor are negative for NICD and Nkx2.5. 
Phalloidin staining (white) illustrates cell bodies. 
A B 
C D 
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Figure 21. Fraction of CPCs positive for NICD and Nkx2.5 after 2, 5 and 8 days of culture under different conditions: uncoated 
(Ctrl), Jagged1-coated (Jag1) and Jagged1-coated treated with γ-secretase inhibitor (Jag1+γ). 
Figure 22. Notch pathway activation (Jag1) and inhibition (Jag1+γ) and Nkx2.5 mRNA levels measured by real time RT-PCR. 
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Figure 23. (A-B) GATA4 expression (yellow) in CPCs stimulated by Jagged1 in the absence (A) and presence (B) of γ-secretase 
inhibitor. (C) Fraction of CPCs positive for GATA4 under different culture conditions. 
. 
A B 
C 
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2.3 Notch1 and cardiac cell differentiation. The recognition that Notch1 activation is linked to 
the expression of Nkx2.5 and myocyte commitment raised the question whether Notch1 
signaling represses or promotes the acquisition of endothelial cell (EC) and smooth muscle cell 
(SMC) lineages by CPCs. Therefore the mRNA quantity for the EC transcription factor Vezf1 
and the SMC transcription factor GATA6 was measured by real time RT-PCR in CPCs treated in 
a manner identical to that discussed above. In the presence of Jagged1, Vezf1 and GATA6 
transcripts decreased consistently over time. Following 8 days of stimulation, a nearly 60% 
reduction in the expression of these transcription factors was detected. This negative response 
was partially reversed by γ-secretase inhibition (Fig. 24). Importantly, the effects of Jagged1 on 
Nkx2.5 and GATA4 mRNA were similar to those shown above at the protein level by 
immunocytochemistry. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24. Notch1 and CPCs differentiation. Notch pathway activation (Jag1) and inhibition (Jag1+γ) and mRNA levels of GATA6, 
GATA4 and Vezf1 measured by real time RT-PCR at 2, 5 and 8 days in culture. Fold change vs. Ctrl at 2 days.. 
. 
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Although Notch1 activation appeared to be selectively coupled with the acquisition of the 
myocyte lineage, these data failed to document whether this cell commitment was accompanied 
by the loss of the replicative potential of newly formed myocyte progenitors. The ability of 
Jagged1 to enhance or inhibit CPCs division was evaluated by the expression of the cell cycle 
protein Ki67 at 5 days. This time point was selected because the number of Nkx2.5 positive 
CPCs reached its maximum at this interval (see above). The up-regulation of the Notch pathway 
resulted in a 2.4 fold increased in CPCs proliferation and nearly 65% of cycling cells was Nkx2.5 
positive (Fig. 25).  
 
Figure 25. (A-C) Proliferation and cardiomyocyte commitment of CPCs. 
Committed cells are positive for the cell cycle marker Ki67 (A, yellow) and for 
Nkx2.5 (B, magenta). (C) Merge. (D) Fractions of Ki67 and Nkx2.5 positive 
cells after Notch pathway activation (Jag1) and inhibition (Jag1+G). 
. 
D 
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Collectively our observations support the notion that Notch1 regulates the transition of CPCs 
from the primitive immature phenotype to the compartment of amplifying myocytes (Fig. 26). 
This cell category has the ability to divide and simultaneously to differentiate (Watt, 1998). In 
stem cell regulated tissues, the pool size of transient amplifying cells defines the growth reserve 
of the organ and its ability to maintain homeostasis and adapt to injury. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26. (A and B) Notch pathway activation and co-localization of NICD (A, green) and Nkx2.5 (B, magenta) in cells positive 
for α-sarcomeric actin (B, red).  
. 
A B 
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3. Molecular mechanism of Nkx2.5 activation. 
 
3.1. RBP-jk binds to the Nkx2.5 promoter. The molecular mechanism by which Notch1 
regulates CPCs differentiation into myocytes is unclear. Notch1 activation may lead to the 
formation of protein complex between RBP-jk and NICD that, in turn, binds to the Nkx2.5 
promoter initiating transcription. To test this hypothesis, lysates of freshly isolated CPCs were 
immunoprecipitated with an antibody against RBP-jk; Western blotting with a NICD-antibody 
was then performed (Fig. 27). This pull-down assay documented that NICD and RBP-jk formed 
a complex in CPCs raising the possibility that RBP-jk is converted by NICD into a transcriptional 
activator of the Nkx2.5 gene. However, the limited number of CPCs in the mouse heart and the 
necessity to implement complex protocols of co-transfection precluded to performing such 
studies in this cell population. We employed the embryonic cell line P19CL6 that upon 
stimulation generates clusters of spontaneously beating myocytes and vascular cells. P19CL6 
cells have been used previously for the analysis of gene expression and myocyte differentiation 
(Brown et al., 2004). 
The RBP-jk transcription factor preferentially binds to DNA regions containing the 5’-GTGGGAA-
3’ sequence (Tun et al., 1994). A perfect consensus site for RBP-jk in the Nkx2.5 promoter was 
identified at position -2209 -2202 from the transcription starting point. To establish whether 
RBP-jk and the promoter of Nkx2.5 form a protein-DNA complex, P19CL6 cells were transfected 
with a plasmid expressing RBP-jk. Nuclear extracts from non-transfected and transfected 
P19CL6 cells were then utilized in an electrophoretic mobility shift assay. An oligonucleotide of 
17bp including the binding site for RBP-jk was used as a probe and a shifted RBP-jk band was 
found. Exposure to excess unlabeled self-oligonucleotide opposed the appearance of the RBP-
jk shifted band while pre-incubation with an RBP-jk antibody super-shifted the protein-DNA 
complex (Fig. 27). 
To confirm the role of Notch1 in the regulation of Nkx2.5 transcription, the association between 
RBP-jk and CPC genomic DNA was analyzed by chromatin immunoprecipitation (ChIP). ChIP 
recognizes the physical interaction of transcription factors with endogenous DNA regulatory 
elements. Formaldehyde cross-linked chromatin was immunoprecipitated with an antibody 
against RBP-jk and the purified DNA fragments were amplified and sequenced. RBP-jk 
occupied the region of the Nkx2.5 promoter containing the -2209/-2202 RBP-jk consensus site 
(Fig. 28). 
The relevance of the data obtained with P19CL6 cells was reinforced by similar studies 
conducted utilizing CPCs obtained from the mouse heart, which were subsequently expanded in 
vitro. CPCs at P8-11 were utilized and ChIP assay was performed. As expected, RBP-jk was 
found to be linked to the Nkx2.5 promoter that comprised the RBP-jk consensus site. Thus a 
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binding site for RBP-jk is located in the promoter region of Nkx2.5, suggesting that Nkx2.5 is a 
novel target gene of Notch1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27. (A) Formation of a protein complex between RBP-jk and NICD in CPCs; immunoprecipitation (IP)/Western blotting (WB) 
of whole protein extract with an antibody anti-RBP-jk and an antibody anti-NICD, respectively. (B) RBP-jk binding to its consensus 
sequence is shown by electorphoretic mobility shift assay in P16CL6 cells transfected (T) with an expression vector for RBP-jk. 
RBP-jk/oligo complex formation is documented by the shifted bands and the specificity of the assay is documented by the 
supershifted band (Co: specific competitor, NS Co: non- specific competitor, Ab: antibody anti-RBP-jk). 
A B 
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Figure 28. (A) RBP-jk binding to the genomic Nkx2.5 promoter is shown by chromatin immunoprecipitation assay in CPCs using an 
antibody anti-RBP-jk. Hes1: positive control, Mef2c: negative control, IgG: isotype control. (B) Sequence of immunoprecipitated 
DNA fragments amplified with promoter-specific Nkx2.5 primers and  (C) sequences alignment.  
  
A 
B 
C 
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3.2. Notch1 enhances Nkx2.5 promoter activity. To establish the function of NICD/RBP-jk 
complex on Nkx2.5 transactivation, we performed a gene reporter assay with an artificial Nkx2.5 
promoter containing 10 Kb of the 5’ flanking region of the gene. P19CL6 were transiently 
transfected with the β-galactosidase reporter construct controlled by the Nkx2.5 promoter. Cells 
were also co-transfected with expression plasmids carrying constitutively active NICD. The 
expression of exogenous NICD was assessed by Western blotting (not shown). In spite of the 
high level of over-expression of NICD, no β-gal activity was detected, suggesting that the 
NICD/RBP-jk complex alone was unable to promote transcription of Nkx2.5. 
The Nkx2.5 promoter/enhancer region is long, complex and contains several binding sites for 
multiple transcription factors. The regulation of the Nkx2.5 gene requires the cooperation of 
several proteins (Brown et al., 2004; Lien et al., 2002). In this regard, the RBP-jk binding 
sequence was found to be located in proximity of one Smad4 and two GATA4 consensus sites 
in the downstream portion of the Nkx2.5 promoter. Of relevance, the transcription of Nkx2.5 
requires the physical interaction of the Nkx2.5 promoter with GATA4 and Smad4 (Brown et al., 
2004). Therefore, P19CL6 cells were co-transfected with NICD, GATA4 and Smad4 expression 
plasmids in various combinations. Maximal Nkx2.5 promoter activity was reached by 
transfection with the three expression plasmids together: GATA4, Smad4 and NICD. With 
respect to baseline, there was a three-fold increase in β-gal enzymatic activity. Importantly, 
NICD increased by nearly 2-fold the activity of the reporter gene induced by GATA4 and Smad4 
combined (Fig. 29). Thus, Notch1 forms a complex with RBP-jk, which in turn enhances 
transcription of the Nkx2.5 gene. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29. Nkx2.5 promoter activation measured by b-galactosidase activity assay after transfection with the indicated combination 
of expression vectors (G4: GATA4, S4: Smad4, N: NICD). Fold changes vs. mock-transfected cells. 
.  
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4. Function of Notch1 in vivo 
 
Our in vitro results are consistent with in vivo observations suggesting that in self-renewing 
organs the Notch pathway may regulate the pool size of transient amplifying cells (Blanpain et 
al., 2006; Lowell et al., 2000). If this possibility would apply to the heart, Notch1 signaling could 
have important implication in the myocardial response to infarction and the ability of the heart to 
sustain extensive myocardial damage. The experimental protocol involved the intraperitoneal 
administration of the g-secretase inhibitor to mice for three days prior to coronary artery ligation 
and myocardial infarction. At the time of surgery, the g-secretase inhibitor was injected 
intramyocardially and animals were continuously treated intraperitoneally for additional 9 days 
up to the time of sacrifice. Control infarcted mice were injected with the vehicle only. Moreover, 
infarcted mice received two injections of BrdU/day for 9 days. This protocol was utilized because 
myocardial infarction in humans is associated with activation of resident CPCs and formation of 
new myocytes in the region bordering the infarct (Beltrami et al., 2001). 
Doublets, triplets and small clusters of CPCs were detected in the viable myocardium adjacent 
to the infarct in both animal groups. Jagged1 was also distributed in the border zone together 
with c-kit positive cells. In the absence of γ-secretase inhibition, the localization of NICD to the 
nucleus of CPCs was accompanied by the expression of Nkx25 (Fig. 30). This adaptation was 
markedly attenuated in mice exposed to the γ-secretase inhibition. 
Quantitatively, blockade of the Notch pathway resulted in a 70% reduction in the pool of CPCs 
distributed in the border zone and in an 80% decrease in the fraction of CPCs expressing NICD 
(Fig. 31). Similarly, the number of CPCs positive for NICD and Nkx2.5 was 84% lower in 
animals treated with the γ-secretase inhibitor. Therefore, the commitment of resident CPCs to 
the myocyte lineage appeared to be impaired by Notch pathway inhibition. 
To test this possibility we measured the extent of cardiomyogenesis at the level of the border 
zone. New myocytes corresponded to small cells that were BrdU and α-sarcomeric actin 
positive. In infarcted mice not exposed to the γ-secretase inhibitor, several regenerated 
myocytes were identified (Fig. 32). In contrast, newly formed myocytes were rarely found in 
animals with blockade of the Notch pathway. Quantitatively, the number of BrdU positive 
myocytes in the border zone was ~50% lower in animals treated with the γ-secretase inhibitor 
(Fig. 32 B). 
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Figure 30. Function of Notch1 in vivo. (A-E) Border 
zone of an acute infarct in control animals; (A and 
B) Small clusters of c-kit-positive CPCs (green, 
arrowheads) co-expressing Notch1 receptor 
(yellow, arrows) are present. (C) Jagged1 
distribution (white, arrows) between c-kit-positive 
cells (green) and cardiomyocytes (a-SA, red). (D 
and E) A cluster of c-kit-positive CPCs (green). One 
c-kit-positive CPC expresses NICD (D, magenta, 
arrow) together with Nkx2.5 (E, yellow, arrow).  
.  
A B 
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Figure 31. Number of c-kit-positive CPCs, fraction and number of CPCs expressing NICD and Nkk2.5 in the border zone of control 
animals (Untreated) and mice treated with g-secretase inhibitor (Treated). Values are mean ± SD. *, P < 0.05 vs. Untreated. (G and 
H) Formation of new myocytes documented by BrdU incorporation.  
.  
Figure 32. (A) Small myocyte (a-SA, red, arrows) with BrdU labeled nucleus (white) is present. (B) Treatment with γ-secretase 
inhibitor results in a reduction in BrdU labeling of myocytes. .  
.  
A 
B 
*  
*  
*  
 48 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foci of spontaneous myocardial regeneration have been found within the infracted heart in 
humans (Urbanek et al., 2005). In agreement with these observations, these sites of 
cardiomyogenesis were detected in a few cases of control animals and were absent in animal 
exposed to γ-secretase inhibition. In the damaged region of non-treated infarcted mice small 
clusters of newly formed BrdU-positive cardiomyocytes were found to be positive for NICD at 
the level of their nuclei (Fig. 33). Importantly, BrdU positive myocytes showed consistently a 
nuclear co-localization of NICD and Nkx2.5 (Fig. 34 and 35). 
Figure 33. (A-C) Spontaneous myocardial regeneration after infarction in untreated mice. (A) Small myocytes (a-SA, red) included 
in the squares and shown at higher magnification in the adjacent panels are positive for NICD (green, arrows). (B and C) Cluster of 
small regenerating myocytes (arrows) in the infarcted area that express NICD (J, green) and are labeled with BrdU (K, white). 
B C 
A 
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Figure 34. (A-D) Small myocytes (a-SA, red) included in the square (A) are shown at higher magnification in panels B-D (arrows). 
Newly formed myocytes are labeled with BrdU (B, white) and express NICD (C, green) together with Nkx2.5 (D, yellow).  
A B 
C D 
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 Figure 35. (A-D) Large focus of myocardial regeneration (new) in proximity to dead myocytes (dead). Newly formed myocytes 
(a-SA, red) are labeled with BrdU (A, white) and express NICD (B, green) together with Nkx2.5 (C, yellow). (D) merge.  
A 
B 
C 
D 
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CONCLUSIONS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 52 
The results of the present study document that the activation of the Notch1 pathway favors the 
commitment of CPCs to the myocyte lineage and controls the size of the compartment of 
transient amplifying myocytes in vitro and in vivo. This behavior may correspond to a model of 
differentiation delay in which sustained up-regulation of Notch1 signaling prolongs the amplifying 
state of CPC-derived myocytes and prevents terminal differentiation and growth arrest. This 
function of Notch1 involves the expression of the transcription factor Nkx2.5, which represent a 
novel target gene of Notch1. The induction of Nkx2.5 is an early event in the growth of 
embryonic myocytes (Schwartz and Olson, 1999), but its function in the postnatal heart remains 
unclear. Our findings indicate that Nkx2.5 drives the commitment of resident CPCs in the adult 
heart possibly controlling the activation or repression of the complex transcriptional network that 
modulates myocyte formation and cardiac homeostasis (Cripps and Olson, 2002; Olson, 2006). 
Notch function in progenitor cells is generally coupled with the preservation of the primitive 
phenotype (Androutsellis-Theotokis et al., 2006; Artavanis-Tsakonas et al., 1999; Calvi et al., 
2003; Wilson et al., 2001). Conversely, Notch ligands promote the maturation of stem cells in 
the basal layer of the skin and satellite cells of the skeletal muscle (Blanpain et al., 2006; 
Kitamura et al., 2007; Lowell et al., 2000). In a similar manner, Jagged1 stimulation coupled with 
the up-regulation of Nkx2.5 favors the entry of CPCs into a pool of cells characterized by the 
acquisition of the myocyte phenotype and the ability to divide. The presence of Nkx2.5 does not 
appear to interfere with the capacity of these cells to proliferate. Nkx2.5 positive cells expressed 
NICD in their nuclei and are consistently labeled by BrdU and Ki67. They also have a thin layer 
of cytoplasm containing sarcomeric proteins. Together these cellular properties define the 
compartment of transient amplifying myocytes (Watt, 1998). In this regard, self-renewing organs 
contain two populations of replicating cells: stem cells and amplifying cells. The latter 
corresponds to the progeny of stem cells, which is destined to acquire complete maturation but 
prior to cell cycle withdrawal experiences a limited number of divisions (Jones and Watt, 1993; 
Watt, 1998). Amplifying cells are short-lived cells with low self-renewal ability and high 
differentiation potential. This cell pool increases the number of daughter cells resulting from 
stem cell division; this growth effect ensures tissue homeostasis, allows stem cells to divide 
rarely and protect the stem cell compartment from depletion (Booth and Potten, 2000). Our data 
after myocardial infarction are consistent with this possibility since Notch1 upregulation in vivo 
expands the population of amplifying myocytes. Successive rounds of Notch1 inhibition and 
activation may results in a controlled exodus of CPCs from the undifferentiated to the committed 
state in which CPCs assume the myogenic fate. The expression of the Notch1 receptor on the 
plasma membrane in the absence of the nuclear translocation of its intracellular domain may be 
linked to a permissive state in which the multipotentiality of CPCs is preserved. 
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The current work has led to the identification of a functional RBP-jk consensus site in the 
promoter region of Nkx2.5 pointing to the critical role that Notch1 signaling has in the regulation 
of myocyte turnover in the adult mouse heart. This possibility is consistent with observations in 
Nkx2.5 null mouse embryos in which the expression of multiple cardiac transcription factors, 
contractile proteins and myocyte membrane proteins is markedly reduced (Lyons et al., 1995; 
Tanaka et al., 1999). Collectively, these findings indicate that Nkx2.5 plays an essential role in 
the transcriptional regulation of the cardiac gene program during development and in the adult 
heart, as suggested by our results. The upregulation of Nkx2.5 with pressure-overload has been 
interpreted as part of the induction of the fetal cardiac phenotype in the stressed myocardium 
(Heineke and Molkentin, 2006). However, Nkx2.5 expression may reflect the activation of 
resident CPCs and the formation of a myocyte progeny rather than being restricted to the 
synthesis of fetal proteins in terminally differentiated post-mitotic cardiomyocytes. Myocyte 
regeneration occurs in animals and human following aortic stenosis, systemic hypertension and 
pulmonary artery banding (Anversa et al., 1990; Olivetti et al., 1988; Urbanek et al., 2003). This 
notion is supported by the function of Nkx2.5 that contributes to the activation of the 
hypertrophic program in the overloaded heart, although this homeobox gene does not 
participate (is not sufficient) in the increase of myocyte size with cardiac hypertrophy (Akazawa 
and Komuro, 2003). Understanding the cellular and molecular events involved in the Nkx2.5-
dependent specification of cell fate may provide important insights on the mechanisms of 
myocardial regeneration in the pathologic heart (Schwartz and Olson, 1999). Modulation of the 
Notch1 pathway may restore the balance between uncommitted and committed cells and 
maintain physiologic cardiac homeostasis in chronic cardiac diseases delaying the onset of 
heart failure. 
The recognition that Jagged1 stimulation and Notch1 signaling in CPCs promote myocyte 
formation and concurrently interfere with the acquisition of the EC and SMC lineages and 
vasculogenesis, emphasizes the importance of this effector pathway in the myocardial response 
to growth stimuli. This model of selective specification of cell fate mimics the function of Notch in 
other stem cell-regulated organs (Artavanis-Tsakonas et al., 1999; Blanpain et al., 2006; 
Tanigaki and Honjo, 2007). Notch may act as a lineage switch between myocyte and vascular 
fates by positively regulating Nkx2.5 and negatively influences the genes required for vascular 
differentiation. The down regulation of the SMC transcription factor GATA6 is consistent with the 
activity of the Notch-dependent repressors of transcription Hey1 and Hey2 on members of the 
GATA family of proteins in the heart and hematopoietic system (Fischer et al., 2005). A similar 
mechanism may be operative for the EC transcription factor Vezf1. The observation that 
transient amplifying myocytes express Nkx2.5 but lack GATA4 raises the possibility that Notch1 
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upregulation is necessary for early myocyte commitment but opposes the acquisition of the adult 
phenotype. 
Several fundamental biologic issues have been addressed by the present investigation. Cell fate 
decision in Stem Cells is crucial for the structural and functional integrity of organs and systems. 
Thus, unrevealing the mechanisms regulating cardiac homeostasis may result in new 
therapeutic approaches to prevent or delay the onset and development of heart failure. 
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METHODS. 
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Cell isolation and CPCs enrichment. 
Cardiac small cells were isolated by enzymatic digestion of the mouse heart and plated o/n in 
F12K plus 20% FBS (high serum). On the following day, cells were labelled with a monoclonal 
antibody anti c-kit conjugated with magnetic beads (Miltenyi Biotech Inc, Auburn, CA) and c-kit 
positive CPCs were selected using MACS Separation Columns (Miltenyi Biotech Inc, Auburn, 
CA) according to the manufacturer instructions. After selection c-kit positive CPCs were 
expanded and starting from three days before the experiment CPCs were gradually starved to 
5% of FBS (low serum). On the day of the experiment the cells were reselected for c-kit as 
above and plated in dishes (40x103 cells for 2 days time point and 20x103 cells for 5 and 8 days 
time point) and in chamber slides (4x103 cells/chamber for 2 days time point and 2x103 
cells/chamber for 5 and 8 days time point). 
 
Stimulation with ligand and g-secretase inhibition. 
Petri dishes and chamber slides were pre-coated with an antibody anti-human IgG1 [25mg/ml] 
(Sigma, St. Louis, MO) and, after washing (PBS + BSA 0.1%), treated with blocking buffer (PBS 
+ BSA 1%) for 1h RT. After the removal of the excess of blocking buffer, dishes and chamber 
slides were coated with the human Fc-Jagged1 chimera [6mg/ml] (R&D Systems, Minneapolis, 
MN) for 2h RT. 
g-secretase inhibitor (Calbiochem, San Diego, CA) was dissolved in DMSO according to the 
manufacturer instructions [2mM]. For the in vitro experiment the treated samples were cultured 
in the presence of g-secretase inhibitor [final: 10 nM] and the control samples with 0.0005% 
DMSO only. Medium was replaced after 2 and 5 days. 
 
Animal treatments. 
Female C57BL/6 mice of two moths of age (n=10) were injected intraperitoneally with g-
secretase inhibitor for 3 days before myocardial infarction (MI). After left coronary occlusion the 
animals were treated for additional 9 days and then sacrificed. Treated animals received 80 
nmols of g-secretase inhibitor per day and, on the day of surgery, 0.25 nmols of g-secretase 
inhibitor by two intra myocardial injections in the border zone of the infarct. Controls animals 
were infracted and treated with the vehicle only. In both groups of animals BrdU was delivered 
by IP injections (50mg/Kg) twice a day for 9 days after MI and in the drinking water (1g/L). 
With mice under tribromoethanol anesthesia, the abdominal aorta was cannulated with a 
polyethylene catheter, PE-50, filled with a phosphate buffer, 0.2 M, pH 7.4, and heparin, 100 
units/ml. In rapid succession, the heart was arrested in diastole by the injection of 0.15 ml of 
CdCl2, 100 mM, through the aortic catheter; the thorax was opened; perfusion with phosphate 
buffer was started; and the vena cava was cut to allow the drainage of blood and perfusate. 
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The aortic catheter was connected to a pressure reservoir to adjust perfusion pressure to mean 
arterial blood pressure measured in vivo. Simultaneously, the left ventricular chamber (LV) was 
filled with fixative, 4% formaldehyde in phosphate buffer from a pressure reservoir set at a 
height equivalent to end-diastolic pressure determined in vivo. 
This was accomplished by inserting a 25G3/4 needle into the LV through the apex. The needle 
was connected to a pressure reservoir. After perfusion with buffer for 2 min, the coronary 
vasculature was perfused for 15 min with fixative. Subsequently, the heart was excised, and 
weights were recorded. The volume of the myocardium in each anatomical region of the heart 
was determined by dividing the weight by the specific gravity of muscle tissue, 1.06 g/ml. 
 
ICC and IHC. 
Cells were fixed with 4% PFA and treated with Triton X100 0.01% for the detection of 
intracellular antigens. Unspecific binding was reduced incubating the cell in 10% BSA for 30’ 
RT. 
The following antibodies were employed for the detection of the antigens of interest: a rabbit 
polyclonal antibody able to recognize NICD, the active form of the Notch1 receptor (Cell 
Signalling Technology, Beverly, MA), a goat polyclonal anti-GATA4 (Santa Cruz Biotechnology, 
Santa Cruz, CA), a goat polyclonal anti-Nkx2.5 (Santa Cruz Biotechnology, Santa Cruz, CA), a 
pre-diluted mouse monoclonal antibody able to recognize the extracellular domain of Notch1 
(Abcam, Cambridge, MA), a goat polyclonal antibody anti-c-kit (R&D Systems, Minneapolis, 
MN), a rabbit polyclonal antibody anti-Ki67 (Vector laboratories Inc., CA) and a mouse 
monoclonal antibody anti-a-sarcomeric actin (Sigma, St. Louis, MO). 
The cell body was revealed by incubation with phalloidin directly conjugated with a 
fluorochrome (Invitrogen Corporation, Carlsbad, CA). 
Paraffin-embedded tissue sections were stained with the following antibodies: a rabbit 
polyclonal antibody anti-c-kit (R&D Systems, Minneapolis, MN), rabbit polyclonal antibody anti-
Nkx2.5 (Santa Cruz Biotechnology, Santa Cruz, CA), a pre-diluted mouse monoclonal antibody 
able to recognize the extracellular domain of Notch1 (Abcam, Cambridge, MA) were utilized. 
For the detection of the active form of Notch1 a rabbit polyclonal antibody anti-NICD (Cell 
Signaling) and the Tyramide Signal Amplification Kit (PerkinElmer Life And Analytical Sciences, 
Inc., Waltham, MA) were employed according to the manufacturer instructions. 
BrdU incorporation was detected with a mouse monoclonal antibody (Roche Applied 
Bioscience, Indianapolis, IN). 
Secondary antibodies, conjugated with the appropriate fluorocome, (Jackson ImmunoResearch, 
West Grove, PA) were employed. Primary and secondary antibodies were utilized following the 
manufacturer instructions. 
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Real time RT-PCR. 
Total RNA was extracted using the RNeasy plus mini kit (Qiagen Inc., Valencia, CA) and RNA 
concentration was measured with the NanoDrop system (NanoDrop Technologies, Wilmington, 
DE). The reactions were performed using the ABI Prism 7300 Real Time PCR Systems 
(Applied Biosystems, Valencia, CA). After DnaseI treatment, an amount of 25 ng of total 
RNA/well was amplified in the presence of the One Step RT-PCR Master Mix Reagent (Applied 
Biosystems, Valencia, CA). 40 amplification cycles were performed. Differently, cDNA to 
identify Nkx2.5 transcript level was generated from 1ug total RNA with High Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems, Valencia, CA) following manufacturer’s 
protocol.  Real-time PCR for Nkx2.5 was performed using Power SYBR Green PCR Master Mix 
(Applied Biosystems, Valencia, CA) according to manufacturer’s instructions. Primers and 
probes were designed using the Integrated DNA Technologies software (IDT, Inc. Coralville, 
IA). 
 
Hes1 
Fw: 5’-CAC GAC ACC GGA CAA ACC A-3’ 
Rev: 5’-GCC GGG AGC TAT CTT TCT TAA GTG-3’ 
Probe: 5’-/56-FAM/AGC CTA TCA TGG AGA AGA GGC GAA GGG CAA/3BHQ_1/-3’ 
Notch1 
Fw: 5’-GTG GAT GAC CTA GGC AAG TCG-3’ 
Rev: 5’-GTC TCC TCC TTG TTG TTC TGC AT-3’ 
Probe: 5’-/56-FAM/TGC TGT TGT GCT CCT GAA GAA CGG AGC CAA/3BHQ_1/-3’ 
GATA4 
Fw: 5’-GAA TAA ATC TAA GAC GCC AGC AGG TCC-3’ 
Rev: 5’-GAC AGC TTC AGA GCA GAC AGC A-3’ 
Probe: 5’-/56-FAM/ATG TCC CAG ACA TTC AGT ACT GTG TCC GGC CA/3BHQ_1/-3’ 
GATA6 
Fw: 5’-AAG CGC GTG CCT TCA TCA C-3’ 
Rev: 5’-GAG CCA CTG CTG TTA CCG GA-3’ 
Probe: 5’-/56-FAM/ATG CTG AGG GTG AGC CTG TGT GCA ATG CTT/3BHQ_1/-3’ 
Vezf1 
Fw: 5’-CCA GGG AAG CAG GTA GAG ACA C-3’ 
Rev: 5’-TTT GAC ATA GTC CCA GAC GAC ACA G-3’ 
Probe: 5’-/56-FAM/AGA AAG AAA GAA GCT GCC AAC CTG TGC CAA/3BHQ_1/-3’ 
Nkx2.5 
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Fw: 5’-CCC AAG TGC TCT CCT GCT TTC C-3’ 
Rev: 5’-ACA GCT CTT TCT TAT CCG CCC GA-3’ 
β-Actin 
Fw: 5’-CTG AAC CCT AAG GCC AAC CG-3’ 
Rev: 5’-CAG CCT GGA TGG CTA CGT AC-3’ 
Probe: 5’-/56-FAM/TGA CCC AGA TCA TGT TTG AGA CCT TCA ACA CCC/3BHQ_1/-3’ 
 
Immunoprecipitation-Western blotting. 
c-kit positive CPCs whole cell extracts were obtained using the M-PER Mammalian Protein 
Extraction Reagent with the addition of the Halt Proteases Inhibitors Cocktail Kit (Pierce 
Biotechnology, Rockford, IL) according to the manufacturer instructions. 
Equivalents of 500 mg of protein extracts were incubated with a rabbit polyclonal anti-RBPjk 
antibody (Santa cruz Biotechology, Santa Cruz, CA) overnight at 4°C on a rotor followed with 
an incubation with G protein-agarose (Invitrogen Corporation, Carlsbad, CA) for 1h at 4°C on a 
rotor. The immunoprecipitates (IPs) were separated by 8% SDS-PAGE and transferred onto a 
nitrocellulose membrane. 
Blots were incubated overnight at 4°C with rabbit polyclonal anti-cleaved Notch1 (Val 1744) 
antibody (Cell Signaling Technology, Beverly, MA). 
Antibodies were used at a concentration suggested by the manufacturer instructions in TBS 
containing 0.1% Tween 20 and 5% non-fat milk. HRP-conjugated IgG were used as secondary 
antibodies. Proteins were detected with ECL (Pierce Biotechnology, Rockford, IL). 
 
Electophoretic mobility shift assay. 
P19CL6 cells were transfected with an expression vector for RBP-jk and nuclear extracts from 
non-transfected and transfected cells were used in this assay. Single-stranded oligonucleotides 
containing the conserved RBP-jk consensus site (GTGGGAA) of the mouse wild type Nkx2.5 
promoter (wild sense: 5’-TAGGGGTGGGAAAGTCA-3’ and wild antisense: 5’-
TGACTTCCCACCCCTA-3’) were end-labeled with T4 polynucleotide kinase (Promega, 
Madison, WI) and [γ32P]-ATP (PerkinElmer Life and Analytical Sciences, Shelton, CT). After 
precipitation, the wild labelled oligonucleotides and the complementary oligonucleotides 
containing a mutated RBP-jk consensus site of the mouse Nkx2.5 promoter (mutated sense: 5’-
TAGGGAGGTAGAGTCA-3’and mutated antisense 5’-GACTCTACCTCCCCTA-3’) were 
annealed and purified by precipitation. Binding reactions (20 μl) were prepared in binding buffer 
(Promega, Madison, WI) with 30 μg of nuclear extract, 4 mCi of labelled oligonucleotide probe 
and incubated 20 min at room temperature. Where indicated, 4 mg of rabbit polyclonal anti-
RBPjk antibody (Santa Cruz Biotechology, Santa Cruz, CA) was added to the binding reactions. 
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For competition assays (specific and unspecific), unlabelled wild type and mutant probes were 
added at the same concentration of the labelled probe. The complexes were resolved by 
electrophoresis on 4% polyacrylamide gels (acrylamide / bisacrylamide at 29:1) in 0.5x Tris 
Buffered EDTA (TBE) buffer containing 2.5% glycerol at 350 V for 40’ RT. The gel was dried 
and exposed to a film overnight at − 80 °C with intensifying screens.  
 
Chromatin immunoprecipitation. 
CPCs and P19CL6 cells were expanded in F12K plus 5% FBS and a-MEM plus 10% FBS, 
respectively to reach ~80-90% confluency at the time of the experiment. On the day of the 
experiment the cells were crosslinked with 1% formaldehyde for 10 min room temperature; cells 
were collected and cell extracts were sonicated for DNA shearing (Artek Sonic Dismembrator 
150). Chromatin was immunoprecipitated with a rabbit polyclonal anti-RBPjk antibody (Santa 
Cruz Biotechnology, Santa Cruz, CA). After decrosslinking, immunoprecipitated DNA fragments 
were treated with RNase and Proteinase K and they were purified with spin columns (QIAGEN 
Inc., Valencia, CA). For PCR analysis three different sets of primers were utilized: Fw: 5’-
GAGGTCACCCCAATTCTGTT-3’ and Rev: 5’-GGGCTTCCA GAGTTGACAAA-3’ for Nkx2.5; 
Fw: 5’-GCCTCTGAGCACAGAAAGGT-3’ and Rev: 5’-CGCCTCTTCTCCCTG ATAGG-3’ for 
HES1 (positive ctrl); Fw: 5’-GACCGACCTGCTTTACTTGA-3’ and Rev: 5’-
TGACACACCAGGCTG TTCAAC-3’ for Mef2c (negative ctrl). 
35 cycles of PCR was performed using 20ng of template. 
The DNA amplicons corresponding to each specific target were eluted from the gel and 
sequenced. 
 
Gene reporter activity assays. 
P19CL6 cells were grown in a-MEM plus 10% FBS and antibiotics. 24h before transfection the 
medium was replaced with antibiotic-free medium. On the day of the experiment (~80% 
confluency), the cells were transfected using Lipofectamine transfection reagent (Invitrogen 
Corporation, Carlsbad, CA); a plasmid carrying the mouse Nkx2.5 upstream of the b-gal 
reporter gene (1mg) was used in three different set of co-transfections along with expression 
vectors carrying the mouse NICD, GATA4 and Smad4 coding sequences (1mg each). The 
Promega pGL3-luc control vector (1mg) was used to define the efficiency of transfection and to 
normalize the data. After transfection the cell extracts were obtained and b-galactosidase and 
luciferase enzyme activity assays were performed (Promega, Madison, WI) according to the 
manufacturer instructions. 
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Cardiac stem cells (CSCs) have been identified in the adult heart,
but the microenvironment that protects the slow-cycling, undif-
ferentiated, and self-renewing CSCs remains to be determined. We
report that the myocardium possesses interstitial structures with
the architectural organization of stem cell niches that harbor
long-term BrdU-retaining cells. The recognition of long-term label-
retaining cells provides functional evidence of resident CSCs in the
myocardium, indicating that the heart is an organ regulated by a
stem cell compartment. Cardiac niches contain CSCs and lineage-
committed cells, which are connected to supporting cells repre-
sented by myocytes and fibroblasts. Connexins and cadherins form
gap and adherens junctions at the interface of CSCs–lineage-
committed cells and supporting cells. The undifferentiated state of
CSCs is coupled with the expression of 4-integrin, which colocal-
izes with the 2-chain of laminin and fibronectin. CSCs divide
symmetrically and asymmetrically, but asymmetric division pre-
dominates, and the replicating CSC gives rise to one daughter CSC
and one daughter committed cell. By this mechanism of growth
kinetics, the pool of primitive CSCs is preserved, and a myocyte
progeny is generated together with endothelial and smooth mus-
cle cells. Thus, CSCs regulate myocyte turnover that is heteroge-
neous across the heart, faster at the apex and atria, and slower at
the base–midregion of the ventricle.
The notion that the heart exerts its function until the death of theorganism with the same myocytes that are present at birth (1)
has been challenged. Activation of cyclins and cyclin-dependent
kinases, BrdU incorporation, and expression of Ki67,MCM5, cdc6,
and phosphohistone-H3 have been shown in myocytes, together
with karyokinesis and cytokinesis (2). The search for the origin of
dividing myocytes led to the identification of a population of
primitive cells with the characteristics of stem cells (SCs) in humans
(3) and animals (4–8). In self-renewing organs, SCs are stored in
niches that constitute the microenvironment in which SCs are
maintained in a quiescent state (9). After activation, SCs replicate
andmigrate out of the niches to sites of cell replacement where they
differentiate and acquire the adult phenotype. Niche homeostasis
is regulated by division of SCs, which preserves the ideal proportion
of primitive and committed cells within the organ (9, 10).
Although cardiac SCs (CSCs) have been found, the myocardial
structure in which CSCs and early lineage-committed cells (LCCs)
are nested together remains to be identified. Similarly, the sup-
porting cells that are intimately connected with the CSCs–LCCs
within the niches have not been recognized. This identification is of
crucial importance, because CSCs cannot exist in the absence of
supporting cells, which anchor SCs to the niche and modulate
growth signals, resulting in the formation of a cardiac progeny.
These biological variables define whether the heart is capable of
significant myocyte regeneration. Asymmetric division of CSCs
generates CSCs and LCCs that move out of the niches and replace
old, poorly contractingmyocytes. Conversely, symmetric division of
a CSC gives rise to two CSCs or two LCCs. Although asymmetric
division may have a prominent impact on niche homeostasis and
myocyte turnover, symmetric division could be involved in emer-
gency situations demanding a rapid formation of CSCs or cardio-
myocytes. SC destiny depends on cell fate determinants, which
include Numb and -adaptin (9, 10), whose role in CSCs is
unknown.
We have identified the components of cardiac niches and the
contribution of CSC symmetric and asymmetric division to heart
homeostasis. The functional properties and growth kinetics ofCSCs
have been defined by BrdU-retaining assays, because the long-term
label-retaining property of a cell documents its stemness, while the
progressive dilution of the label identifies the formed progeny (11).
Results
CSC Clusters. Although a niche can include a single SC, we have
directed our search to clusters of CSCs and early LCCs. These nests
were present in the atria, base–midregion, and apex, and consisted
of lineage-negative (Lin) c-kit, MDR1, or Sca-1 cells assem-
bled with LCCs. By definition, CSCs exhibit SC antigens (c-kit,
MDR1, Sca-1) but do not express transcription factors or mem-
brane and cytoplasmic proteins of cardiac cells (3, 5). Progenitors
correspond to cells in which the epitope of stemness coexists with
transcription factors indicative of myocytes, endothelial cells (ECs),
or smooth muscle cells. Precursors are a step farther in the
differentiation process: The cytoplasm contains specific myocyte,
EC, or smooth muscle cell proteins. More differentiated cells
possess lineage-related nuclear and cytoplasmic proteins in the
absence of SC antigens (Fig. 1 A–C). Capillaries were occasionally
seen at the periphery of pockets of CSCs–LCCs, which were all
CD45-negative (Fig. 6 and Table 1, which are published as sup-
porting information on the PNAS web site). The sporadic and
scattered location of capillaries within the niches, together with the
absence of hematopoietic cell markers on CSCs, pointed to the
non-bone marrow origin of cardiac primitive cells.
Supporting Cells. Connexin 43 and 45 and N- and E-cadherin were
found between twoLinCSCs, one LinCSCand oneLCC, or two
LCCs. These proteins were also detected between CSCs–LCCs and
myocytes and fibroblasts (Fig. 1 D–J). However, they were not
observed between CSCs–LCCs and ECs or smooth muscle cells.
The expression of connexins and cadherins in isolated c-kit
CSCs–LCCs was confirmed by Western blotting. The specificity of
this protocol was strengthened by the fact that these cell prepara-
tions were negative for markers of myocyte differentiation, such as
myosin light chain 2v (Fig. 7, which is published as supporting
information on the PNAS web site).
A functional assay was performed to document the role of
connexins in the formation of gap junctions between c-kit CSCs–
LCCs andmyocytes, fibroblasts, or ECs. Cell coupling was analyzed
in vitro by two-photon microscopy after preincubation and loading
of c-kit CSCs–LCCs with the green fluorescent dye calcein. The
cells were also labeledwith the red fluorescent dye 1,1-dioctadecyl-
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3,3,3,3-tetramethylindocarbocyanine, which integrates stably
within the cell membrane (12). Labeled c-kit CSCs–LCCs (green
and red) were plated with unlabeled myocytes, fibroblasts, or ECs.
The appearance of green fluorescence in unlabeled cells, in the
absence of red fluorescence, indicated the transfer of calcein
through the formation of gap junctions. Calcein translocated from
c-kit CSCs–LCCs to myocytes and fibroblasts but not to ECs,
suggesting that myocytes and fibroblasts function as supporting
cells. This finding was confirmed by the identification of connexin
43 and 45 between c-kitCSCs–LCCs andmyocytes and fibroblasts
by confocal microscopy (Fig. 2). When the gap junction-blocker
heptanol was added to the coculture of c-kit CSCs–LCCs and
myocytes, calcein transfer did not occur, despite the expression of
connexin at the interface of the two cell types (see Figs. 8 and 9,
which are published as supporting information on the PNAS web
site).
Integrin Receptors. In the niches, 4-integrin defined the plasma
membrane of LinCSCs; it was not expressed inLCCs (Fig. 3A and
B). 1-integrin was detected in both CSCs and LCCs (Fig. 3 C and
D). The 2-chain of laminin paralleled the localization of 4-
integrin (Fig. 3 E–H). Laminin-89 and -1011 were present in the
niches and myocardium (data not shown). Niches were surrounded
by myocytes, but a basal lamina was not observed. Fibronectin
accumulated on the surface of LinCSCs together with 4-integrin
(see Figs. 10 and 11, which are published as supporting information
on the PNAS web site). The colocalization of the 2-chain of
laminin and fibronectin with 4-integrin was restricted to Lin
CSCs, suggesting that this discrete ligand–receptor interaction was
implicated in the preservation of the undifferentiated state ofCSCs.
In this regard, inhibition of 4-integrin promotes mobilization of
bone marrow progenitor cells (13), providing evidence for the
critical role of 4-integrin in CSC homeostasis. Also, 4-integrin
induces the renewal of hematopoietic SCs (14).
Fig. 1. Cardiac niches and putative supporting cells. Apical
(A, B, and F) and atrial (C–E) niches contain CSCs and LCCs. (A)
Fourteen c-kit cells (green) express Ets1 (white dots) in two
nuclei (EC progenitors, arrowheads). (B) Fourteen MDR1 cells
(white) express GATA-4 (magenta dots) in nine nuclei; six of
the nine GATA-4 cells express -sarcomeric-actin in the cyto-
plasm (red; myocyte precursors, arrows). Three cells positive
for GATA-4 only correspond to cardiac progenitors (arrow-
heads). One small, developing myocyte is visible (asterisk). Five
cells express only MDR1 and are lineage-negative (Lin)
(CSCs). (C) Twenty-three Sca-1 cells (yellow) express MEF2C
(white dots) in 9 nuclei (myocyte progenitors, arrowheads);
one Sca-1 cell is labeled by von Willebrand factor (green; EC
precursor, arrowheads). ECs are also present (asterisks). (D–F)
Localization of connexin 43 and E- and N-cadherin in niches
containing c-kit (D and F, green) and Sca-1 (E, yellow) CSCs
and LCCs. CSCs are Lin; LCCs express GATA-4 (D, magenta-
dots) and MEF2C (E and F, yellow dots). Connexin 43 (yellow
dots), E-cadherin (green dots), and N-cadherin (white dots) are
located between two CSCs (Dand F, arrowheads), a CSC and an
LCC (F, open arrowhead), an LCC and a fibroblast (E, vimentin,
white, double arrowhead), a CSC or an LCC and a myocyte (D
and F, arrows), and two LCCs (D, open arrow). (G–J) Connexin
43 and 45 and N- and E-cadherin in atrial niches containing
c-kit CSCs–LCCs (green) are represented by yellow dots lo-
cated between two CSCs–LCCs (arrowheads), a CSC–LCC and a
fibroblast (arrows), and a CSC–LCC and a myocyte (double
arrowheads); see Insets. Nuclei are stained by propidium io-
dide (blue). (Scale bars, 10 m.)
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Cardiac Niches. Niches were defined as randomly oriented ellipsoid
structures constituted by cellular and extracellular components.
Fifty niches each were measured in the atria, base–midregion, and
apex. The average volume of niches was 11,000 m3. However,
atrial niches were 2.0-fold larger than ventricular niches. The
number of niches per mm3 of atrial and apical myocardium was
8-fold higher than at the base–midregion (Fig. 12, which is
published as supporting information on the PNAS web site). The
number of CSCs–LCCswithin atrial niches was higher than in other
fixation and staining by confocal microscopy (H). Connexin 43 between the
cells is depicted by yellow dots (H and I, arrowheads). (I) Merge of G and H.
(Scale bars, 10 m.)
Fig. 2. Formation of gap junctions. (A and B) Localization of connexin 43
(A, yellow dots, arrows) between the projection of a c-kit CSC–LCC (B,
vimentin, green) and an unlabeled myocyte (B, vimentin-negative) in
culture. Connexin 43 is present in other areas of the myocyte surface (A,
arrowheads). (C–F) Two-photon microscopy of c-kit CSCs–LCCs loaded
with calcein and 1,1-dioctadecyl-3,3,3,3-tetramethylindocarbocyanine
(yellow fluorescence) and cocultured with unlabeled fibroblasts or unla-
beled myocytes. Green fluorescence in fibroblasts (C and D) and myocytes
(E and F) demonstrates the translocation of calcein (green) from CSCs–LCCs
to fibroblasts and myocytes. (G–I) Two-photon microscopy of a myocyte
and adjacent CSC–LCC (G). Calcein–1,1-dioctadecyl-3,3,3,3-tetramethyl-
indocarbocyanine (orange) is apparent in the CSC–LCC (arrows) but not in
the myocyte, which is calcein only (green). The same cells are shown after
Fig. 3. Cardiac niches, integrin receptors, and extracellular ligands. Apical
(A–D) and atrial (E–H) niches contain integrin subunits and laminin. (A–D) The
same niche is illustrated at two distinct levels: One (A and B) and two (C and
D). c-kit cells (A, green), which do not express GATA-4 in their nuclei (A and
B, white dots), possess 4-integrin on the cell surface (B, magenta, arrows).
However, c-kit cells (C, green), which express or do not express GATA-4 (Cand
D, white dots) possess 1-integrin (D, yellow). (E–H) The 2-chain of laminin (E,
F, and H, yellow) is associated with 4-integrin (F–H, magenta) in four of the
nine c-kit cells (GandH, green, arrows). The four2-laminin4-integrin c-kit
cells are negative for GATA-4; GATA-4 is present in the other five c-kit cells
(H, white dots). (Scale bars, 10 m.)
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areas and depended on the size of the niches. Atria and apex were
the preferential storage sites of Lin CSCs (Fig. 12).
Long-Term Label-Retaining Assay. Four and 12 injections of BrdU
were performed at 12-hour intervals in two groups of mice over a
period of 2 and 6 days, respectively. A third group was treated in an
identical manner for 6 days, and animals were killed after a chasing
period of 10 weeks. Bright and dim BrdU-labeled Lin CSCs were
distinguished on the basis of fluorescence intensity (Fig. 4A–D, and
seeMaterials andMethods). The number of bright BrdU-LinCSCs
in the atrial niches increased 140% from 2 to 6 days but decreased
91% after 10 weeks of chasing. Of 257 bright BrdU-Lin CSCs at
6 days, only 23 cells retained this characteristic at 10 weeks,
constituting the slow-cycling SC pool in this portion of the heart
(Fig. 13, which is published as supporting information on the PNAS
web site). At the base–midregion and apex, bright BrdU-LinCSCs
increased 80% and 130% from 2 to 6 days and decreased 88% and
91% after chasing, respectively. Dim BrdU-Lin CSCs increased
from to 2 to 6 days, but, in contrast to bright BrdU-LinCSCs, dim
BrdU-Lin CSCs increased dramatically after chasing: 16-fold in
the atria, 13-fold at the base–midregion, and 16-fold at the apex
(Fig. 13). The aggregate number of LinCSCswithin the niches did
not change over a period of 10 weeks in young mice. Thus, the
growth kinetics of LinCSCs tends to preserve the pool of primitive
cells within the niches. The recognition of long-term label-retaining
cells provides functional evidence of resident CSCs in the adult
heart.
Division of CSCs. The long-term label-retaining assay indicated that
10% of LinCSCs are slow-cycling and conform to the paradigm
of SCs. The BrdU pulsechase protocol, however, did not provide
information regarding the pattern of growth at the single SC level.
For this purpose, numerous niche profiles were viewed (Table 2,
which is published as supporting information on the PNAS web
site), and 18, 17, and 20 Linc-kit CSCs in mitosis were detected
in the atria, base-midregion, and apex, respectively. The presence of
Numb and -adaptin at the two poles of cycling CSCs (for sym-
metric division, see Fig. 4 E–G) and the restricted localization of
Fig. 4. CSC growth in cardiac niches. (A–D) Atrial niches with bright (arrows) and dim (arrowheads) BrdU (yellow) c-kit cells (green) after 6 days of labeling
(A and B illustrate the same field) and 10 weeks of chasing period (C andD illustrate the same field). Niches contain c-kit LCCs (transcription factors, white dots;
cardiac myosin and desmin, red) and c-kitLinCSCs (B andD, asterisks). (D) Three LinCSCs, one of which is BrdU-bright (arrow). Two dim BrdU-labeled myocytes
are present (C and D, double arrowheads). (E–G) Atrial niche with seven c-kit cells (green), three of which express GATA-4 (E, white dots). One GATA-4c-kit
cell (E, arrow) expresses phospho-H3 (F, yellow, arrow) and shows -adaptin at both poles of the cell (G, magenta, arrows). The nonmitotic -adaptinGATA-4
cell may represent a recently formed daughter CSC (G, arrowhead). The two remaining c-kitGATA-4 cells may correspond to quiescent CSCs (E andG, asterisks).
(H–J) Atrial niche with seven c-kit cells (green), five of which express GATA-4 (H, white dots). One GATA-4c-kit cell (H, arrow) expresses phospho-H3 (I, yellow)
and shows Numb at one pole of the cell (J, magenta, arrow). The remaining c-kitGATA-4 cell may correspond to a quiescent CSC (H and J, asterisks). (K–N) Two
c-kit cells (green) in culture at the end of mitosis are illustrated in the xy (K and M) and the xz (L and N) plane. The absence (K and L) and presence (M and N)
of GATA-4 (magenta dots) suggest symmetric and asymmetric division, respectively. (Scale bars, 10 m.)
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these proteins at one pole (for asymmetric division, see Fig. 4H–J)
were identified; of the 18 dividing atrial CSCs, 14 were undergoing
asymmetric division, and 4 were undergoing symmetric division.
Corresponding values at the base–midregion were 10 asymmetric
and 7 symmetric and, at the apex, 14 asymmetric and 6 symmetric.
Thus, asymmetric division was more prevalent than symmetric
division (P  0.02).
The CSC mitotic index did not vary in the three portions of the
heart, and, because of the low frequency of CSC mitosis, it was
difficult to establish whether groups of niches were preferentially
activated. Similarly, the limited sampling of mitotic CSCs in each
cardiac region did not allow us to establish whether this process had
a privileged anatomical localization. To obtain additional informa-
tion about CSC proliferation, c-kit cells were cultured in growth
medium to promote cell division. On the basis of the compartmen-
talization of -adaptin and Numb, symmetric division accounted
for 38 7% and asymmetric division for 62 7%. These patterns
of cell growth were confirmed by the detection of GATA-4 as a
marker of cell commitment (Fig. 4 K–N).
Myocyte Turnover. Myocyte formation was assessed by measuring
the fraction of BrdU cells 6 days after BrdU administration and
after 10 weeks of chasing. BrdU-bright myocytes at 10 weeks were
cells that experienced a limited number of divisions, whereas more
rounds of doublings had to occur in myocytes with intermediate
levels of labeling. These myocyte classes were assumed to corre-
spond to amplifyingmyocytes, which incorporatedBrdUat the time
of injection and continued to divide and differentiate. Conversely,
BrdU-dim myocytes were considered the progeny of cycling CSCs,
which becameBrdU at the timeof injection and gave rise to a large
number of committed cells. Clusters of BrdU-dim myocytes, to-
gether with BrdU-bright myocytes, were observed in the ventricle,
whereas a more dispersed pattern of labeling was seen in the atria
and apex (Fig. 5A andB). The percentage of BrdU-brightmyocytes
detected at 6 days decreased markedly after 10 weeks, whereas
BrdU-dim myocytes increased (Fig. 5C).
The apex had 19% BrdU-labeled myocytes, the atria 15%, and
the base–midregion 10%. The BrdU data at 6 days and at 10 weeks
provided us with the magnitude of cell turnover in the myocardium
(see Materials and Methods). These results were complemented
with the measurements of myocyte progenitors–precursors (LCCs)
(Table 3, which is published as supporting information on thePNAS
web site), which, together with the CSC number, were used to
evaluate the half-life of myocytes. Myocytes located at the base–
midregion have a half-life 2-fold longer than atrial and apical
myocytes, suggesting that myocyte turnover is high (Fig. 5D).
Fig. 5. Myocyte turnover and life span. (A and B) Apical section illustrating bright (arrows), intermediate (open arrowheads), and dim (arrowheads) BrdU myocyte
nuclei (yellow)after10weeksof chasing.Myocytesare stainedbycardiacmyosin (B, red). (Scalebar,10m.) (C)Bars showthepercentageofBrdU-bright, -intermediate,
and -dim myocyte nuclei after 6-day labeling and after 10-week chasing. (Right) Bars document the total number of BrdU myocytes (labeled) and the total number
of myocytes in the atria, base–midregion, and apex. *, P 0.05 vs. 6 days. (D) Myocyte half-life. * and **, P 0.05 vs. atria and base–midregion, respectively.
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Discussion
The heart typically shows discrete structures in the interstitium
where CSCs and LCCs are clustered together, forming cardiac
niches. The documentation that SC niches are present in the adult
myocardium has been based on the identification of these pockets
of CSCs–LCCs and the detection of cell-to-cell contact between
CSCs–LCCs and myocytes and fibroblasts. In the heart and other
self-renewing organs, SCs are connected structurally and function-
ally to the supporting cells by junctional and adhesion proteins
represented by connexins and cadherins (15). Connexins are gap
junction channel proteins that mediate passage of small molecules
involved in cell-to-cell communication (16). Cadherins are calcium-
dependent transmembrane adhesion molecules, which have a dual
function: They anchor SCs to their microenvironment and promote
a cross-talk between SCs and between SCs and nurse cells (15).
Cardiac niches create the necessary, permissive milieu for the
long-term residence, survival, and growth of CSCs.
The arrangement of CSCs–LCCs and supporting cells in the
cardiac niches is similar to that found in the bone marrow (17) and
brain (18), providing elements of analogy for these organs. In the
bone marrow, osteoblasts and stromal cells function as supporting
cells (18, 19). They can be considered the equivalent of myocytes
and fibroblasts found here in the heart. ECs do not operate as nurse
cells in the heart, but ECs are the candidate supporting cells in the
brain (20) andmay have a comparable role in the bonemarrow (21).
An uninterrupted basal lamina delimits neural and epithelial
niches, but it is not present in the bone marrow (9) or, as shown
here, in the heart.
Integrins are adhesion receptors for the attachment of cells to the
extracellular proteins fibronectin and laminin (22). 1-Integrin is
commonly found on the surface membrane of primitive and com-
mitted cells within the niches (23). Fibronectin and the 2-chain of
laminin are ligands for 41-integrin (23, 24). The colocalization of
the 2-chain of laminin and fibronectin with 4-integrin was re-
stricted to Lin CSCs, suggesting that 4-integrin binding may be
typically involved in the preservation of stemness of CSCs. 1-
Integrin is highly expressed on the interfollicular SCs of the
epidermis (11) and in neural SCs (23), whereas4-integrin has been
linked to the renewal of hematopoietic SCs (14). The 2-chain of
laminin is detected in SCs of the skin and intestinal crypts (25) but
is not seen in bone marrow SCs (26). Laminin-89 and -1011 are
typical components of bone marrow niches (26) but lack this
preferential localization in the heart. By inference, in cardiac niches,
the 2-chain of laminin and fibronectin transduce mechanical
signals from the extracellular compartment to the 41-integrin
receptor, which activates effector pathways opposing CSC commit-
ment and differentiation.
Homeostasis of cardiac niches is mediated by asymmetric and
symmetric division of CSCs. Asymmetric division predominates,
and, by this mechanism, CSCs protect their pool and generate a
committed progeny. The uniform and nonuniform localization of
Numb and -adaptin, together with the identification of phospho-
histone-H3 expression, (3) was determined to define symmetric and
asymmetric division, respectively. The intracellular segregation of
these proteins at the time of mitosis constitutes the intrinsic
determinant of SC fate. Numb and -adaptin interact to enable
primitive cells to produce differently destined sibling cells (27).
Numb is expressed from late prophase to telophase and in the early
stages of life of the daughter cell (28). Numb localizes to endocytic
vesicles, where it binds to the endocytic protein -adaptin, promot-
ing the internalization and inactivation of the Notch receptor (29).
Numb-negative cells retain their responsiveness toNotch and adopt
the fate associated with Notch activation (30).
The prevailing inhomogeneous localization of Numb and
-adaptin in cycling CSCs controls the production of daughter cells,
which follow divergent paths. The BrdU pulsechase assay con-
formed to this pattern of asymmetric CSC division. Over time, the
number of CSCs–LCCs confined to the niches remains constant,
suggesting that asymmetric kinetics characterizes most of the
growth of CSCs in themyocardium. Thismechanism of cell renewal
has been described as ‘‘invariant’’ (11), and it typically occurs in an
organ in a steady state. Pathological conditions, including ischemia-
reperfusion injury lead to the formation of reactive oxygen species.
Oxidative stress triggers distinct cellular responses; low levels
initiate growth, intermediate degrees promote apoptosis, and high
magnitudesmediate cell necrosis (31).WhetherCSCs–LCCswithin
the niches react to the oxidative challenge in a similar manner is a
critical, unanswered question.
Materials and Methods
Hearts of FVBN mice at 3 months of age were studied. The
volume, composition, and number of cardiac nichesweremeasured.
A subgroup of animals was injected with BrdU for 2 and 6 days and
killed at 2 days, 6 days, and after 10 weeks of chasing. By this
approach, bright and dimBrdUCSCs andmyocytes were counted
(see Supporting Materials and Methods and Table 4, which are
published as supporting information on the PNAS web site).
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